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Manuscript 
Interventions for orthodontically-induced white spot lesions: a systematic review 
and meta-analysis 
 
Summary 
Background: Although orthodontic white spot lesions (WSLs) are one of the most often and most evident 
adverse effects of comprehensive fixed appliance treatment, the efficacy of interventions for WSLs have not 
yet been adequately assessed in an evidence-based manner. 
Objective: Aim of this systematic review was to assess the therapeutic and adverse effects of interventions 
to treat post-orthodontic WSLs from randomized trials on human patients. 
Search methods: An unrestricted electronic search of eight databases from inception to May 2016. 
Selection criteria: Randomized controlled trials assessing any interventions for post-orthodontic WSLs on 
human patients. 
Data collection and analysis: After duplicate study selection, data extraction, and risk of bias assessment 
according to the Cochrane guidelines, random-effects meta-analyses of mean differences (MDs), 
standardized mean differences (SMDs), and odds ratios (ORs), including their 95% confidence intervals 
(CIs) were performed, followed by subgroup and sensitivity analyses. 
Results: A total of 20 unique studies and a total of 942 (42% male/58% female) patients were included, 
with an average age of 16.2 years and a mean number of 8.2 WSLs (range 2.2 to 45.4) per patient. These 
were allocated to adjunct treatment with casein phosphopeptide-stabilized amorphous calcium phosphate 
creams, external tooth bleaching, low or high-concentration fluoride films, gels, mouthrinses or varnishs, 
resin infiltration, miswak chewing sticks, bioactive glass toothpastse or to no adjunct treatment (i.e. 
conventional oral hygiene). The monthly use of fluoride varnish was the best supplement to improve WSLs 
in terms of lesion area (1 trial; MD=-0.80; 95% CI=-1.10,-0.50; P<0.05; high quality) and enamel 
fluorescence (3 trials; SMD=-0.92; 95% CI=-1.32,-0.52; P<0.05; high quality), followed by the use of fluoride 
film. WSL treatment did not provide a considerable improvement in their clinical evaluation (3 trials; 
OR=0.97; 95% CI=0.60,1.56; P>0.05; moderate quality), with imprecision due to small sample size being 
the main limitation of existing evidence. 
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Conclusions: Based on existing trials, interventions for post-orthodontic WSLs, mainly fluoride varnish, 
seem to be effective, but further research is needed to elucidate their clinical relevance. 
Registration: PROSPERO (CRD42016037538) 
Funding: None. 
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Introduction 
Rationale 
Although fixed appliance treatment has become an integral part of modern orthodontics, it has also been associated 
with certain adverse effects. Among these, White Spot Lesions (WSLs) are, as they have a negative impact on the 
esthetic outcome of orthodontic treatment and might progress into carious lesions (1). 
The reported prevalence of WSLs varies considerably, depending on the measurement method/ criteria, 
inclusion of pre-existing developmental enamel defects, and whether tooth surfaces, teeth or patients are used as 
reference unit. Wilmot and Brook (2) reported that every third (37%) treated patient had at least one new post-
orthodontic WSL, while 24% of treated teeth developed at least one WSL (3), with the teeth most affected being the 
maxillary and mandibular first molars, maxillary lateral incisors, mandibular lateral incisors, and mandibular canines 
(4). Although treatment duration can influence the prevalence and severity of WSLs (5), WSLs can develop also within 
the first four weeks of fixed appliance treatment (6). 
Several preventive measures have been suggested to avoid or reduce the development of WSLs during fixed 
appliance treatment, including fluoride-releasing glass ionomer cements for bonding and banding (5), daily use of a 
fluoride mouthrinse (7), and the use of lingual orthodontic appliances (8). A recent systematic review (7) found that 
although such preventive measures during orthodontic treatment might be promising in the short term, robust evidence 
on their effect during the complete span of orthodontic treatment is lacking. 
After removal of fixed appliances a considerable improvement of WSLs is seen during the first 6-24 months 
(9). This observed clinical shrinkage or healing of WSLs after orthodontic treatment can be explained by three factors: 
(a) removal of an etiologic factor (cariogenic plaque adhered to fixed orthodontic elements) and the return of S. mutans 
and Lactobacillus spp. to their baseline levels (10) combined with (b) abrasion of the surface enamel during tooth 
brushing (9) and also (c) with remineralization through the use of a fluoride-containing dentifrice or mouthrinse (5, 
11–13). However, many WSLs persevere even a decade after appliance removal (9) and remain a cosmetic problem. 
Interventions for the treatment of WSLs after appliance removal move mainly in two axes. Firstly, remineralization of 
WSLs takes place naturally to a certain degree after appliance removal and the shift to a more enamel-friendly 
ecosystem (13). However, interventions such as topical fluoride, Casein Phosphopeptide Amorphous Calcium 
Phosphate (CPP-ACP), or self-assembling peptides have also been used as adjuncts to daily use of fluoride toothpaste 
to enhance remineralization and improve its efficacy. Secondly, other more invasive techniques like bleaching, the 
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hydrochloric acid-pumice microabrasion technique (14) or resin infiltration have been implemented in an attempt to 
improve the clinical appearance of WSLs. 
Previous systematic reviews on the subject (15, 16) suffered from issues usually found in similar orthodontic 
publications (17-19) like limited literature search (15, 16) or no use of widely-accepted frameworks for the evaluation 
of the strength of evidence (15) or focused on a single category of interventions (15); none of them (15, 16) performed 
meta-analysis to quantify the treatment effects of the various interventions and the associated uncertainty around them.  
 
Objectives 
Aim of this present systematic review was to critically assess the evidence from randomized clinical trials on humans 
investigating interventions aimed to treat or alleviate WSLs of teeth that originated from a previous comprehensive 
fixed appliance therapy and to conduct meta-analysis, if possible. 
 
Materials and Methods 
Protocol and registration 
The protocol for this review was made a priori based on the PRISMA-P statement (20), registered in PROSPERO 
(CRD42016037538), and all post hoc changes were appropriately noted. This systematic review was conducted and 
reported according to Cochrane Handbook (21) and PRISMA statement (22), respectively.  
 
Eligibility criteria 
According to the Participants-Intervention-Comparison-Outcome-Study design schema (PICOS), we included parallel 
or split-mouth randomized and quasi-randomized prospective controlled trials on human patients comparing any 
intervention for WSLs that were induced from a previous orthodontic treatment to a control/placebo group or to another 
intervention and assessing therapeutic effects (both effectiveness and efficacy) or adverse effects (Appendix 1). 
Excluded were non-clinical studies, retrospective studies, animal studies, and studies on intervention for the prevention 
or treatment of WSLs during orthodontic treatment. 
 
Information sources and literature search 
A total of eight electronic databases were searched systematically by two authors (DM, MHZ) without any limitations 
from inception up to May 9th, 2016 (Appendix 2). Two additional sources (Google Scholar and ISRCTN registry) 
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were manually searched for additional trials or protocols by the same authors. Authors of included trials were contacted 
for additional missed or ongoing trials. No limitations concerning language, publication year or status were applied. 
The reference lists and citation lists of the included trials and relevant reviews were manually searched as well. 
 
Study selection 
Titles identified from the search were screened by one author (DM) with a subsequent duplicate independent checking 
of their abstracts/full-texts against the eligibility criteria by a second author (MHZ), while conflicts were resolved by 
a third author (SNP). 
 
Data collection 
Characteristics of included trials and numerical data were extracted in duplicate by two authors (DM, MHZ) using pre-
determined and piloted extraction forms. Piloting of the forms was performed during the protocol stage until over 90% 
agreement was reached. Missing or unclear information was requested by the trials’ authors. 
 
Risk of bias in individual trials 
The risk of bias of the included trials was assessed using Cochrane’s risk of bias tool (21) after initial calibration. A 
main risk of bias assessment was included in the systematic review pertaining to each trial’s primary outcome. 
 
Data synthesis 
As the outcome of WSL treatment is bound to be affected by the initial lesion characteristics, used substance, company, 
and procedure used, as well as patient characteristics, a random-effects model according to DerSimonian and Laird 
(23) was deemed appropriate to incorporate this variability (24). 
The Mean Difference (MD) and the Odds Ratio (OR) with their corresponding 95% Confidence Interval (CI) 
were chosen as effect measures for continuous and binary outcomes, respectively. For split-mouth trials, where 
clustering was not taken into account during the analysis, we additionally tried to contact the trial’s authors to request 
raw data or clustering-adjusted estimates. 
Between-trial heterogeneity was quantified with the I² statistic, defined as the proportion of total variability 
in the results explained by heterogeneity, and not chance (25). The 95% uncertainty intervals (95% UI) (similar to CIs) 
around the I2 were calculated (26) using the non-central χ2 approximation of Q (27). 95% predictive intervals were 
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calculated for meta-analyses of three trials or more, which incorporate existing heterogeneity and provide a range of 
possible effects for a future clinical setting (19). All analyses were run in Stata SE 10.0 (StataCorp, College Station, 
TX) by one author (SNP). A two-tailed P-value < 0.05 was considered significant for hypothesis-testing, except for P 
< 0.10 used for the test of heterogeneity (28).  
 
Risk of bias across studies 
The overall quality of evidence for each of the main outcomes was rated as very low, low, moderate or high using the 
GRADE approach (18). For this assessment, the risk of bias of each included trial was re-assessed separately at 
outcome level. 
The minimal clinical important, large, and very large effects were conventionally defined (29) as half, one, 
and two standard deviations, respectively. The standard deviation for an outcome was averaged from control groups 
of the existing trials. Conventional cut-offs of 1.5, 2.5, and 4.3 were adopted for the OR. The produced forest plots 
were augmented with contours denoting the magnitude of the observed effects (30). Finally, the optimal information 
size (i.e. required meta-analysis sample size) was calculated for each outcome independently for α = 5% and β = 20%. 
 
Additional analyses 
Possible sources of heterogeneity were planned to be sought through pre-specified mixed-effects subgroup analyses 
and random-effects meta-regression with the Knapp and Hartung (31) adjustment in meta-analyses of at least five 
trials. Indications of reporting biases (including small-study effects) were planned to be assessed with Egger’s linear 
regression test (32) and contour-enhanced funnel plots, should ten or more trials be pooled. 
 
Sensitivity analyses 
Robustness of the results was planned a priori to be checked with sensitivity analyses based on (i) inclusion/exclusion 
of trials with low risk of bias, (ii) improvement of the GRADE classification, and (iii) inclusion/exclusion of cluster 
randomized trials. We additionally performed two post hoc sensitivity analyses: one to investigate the robustness of 
different WSL evaluation methods and one to assess the effect of included number of WSLs/ patient on the results. 
 
Results 
Study selection 
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A total of 594 and 37 papers were identified through electronic (Appendix 2) and manual searches, respectively (Fig. 
1). After removal of duplicates and initial screening, 55 papers were assessed using the eligibility criteria, and 22 
papers were included in this systematic review (Fig. 1; Appendix 3). In one instance, duplicate publications pertaining 
to the same trial were grouped together; thus, a total of 20 trials from 22 publications were finally included in the 
systematic review. 
 
Study characteristics 
The characteristics of the trials included can be seen in Table 1. Of the 20 trials included, 17 (85%) were parallel 
randomized and 3 (15%) were cluster randomized trials, conducted in 12 different countries. They included a total of 
942 patients (mean 47.1; range 11 to 211) with at least 338 male (42.4%) and 460 female (57.6%) patients (gender was 
not specified in five trials), and with an average age of 16.1 years. Where the information was available, the WSLs 
that were acquired during the orthodontic fixed appliance phase were treated either directly following debonding or 
after an intermediate period of up to 14 years. According to their eligibility criteria and protocol, the included trials 
reported a mean of 8.2 WSLs per patient (range 2.2 to 45.4). A wide variety of interventions were used to treat the 
WSLs including CPP-ACP creams (with or without fluoride), external tooth bleaching, low or high-concentration 
fluoride materials (in form of film, gel, mouthrinse, toothpaste or varnish), resin infiltration, miswak chewing sticks 
or bioactive glass toothpaste. After application, the patients were followed for periods ranging from a couple weeks to 
6.5 months and investigated outcomes included among others clinical assessments, intraoral photographs, QLF or laser 
fluorescence methods, estimation of tooth color according to CIE, and patient questionnaires (Table 1). 
 
Risk of bias within studies 
The risk of bias assessment for the 20 trials included is shown in Fig. 2. High risk of bias was found in 11 trials (55%) 
for at least one bias domain. The most problematic domains were the blinding of outcome assessors (problematic in 
30% of the trials), followed by selective reporting (found in 25% of the trials), and other risk of bias (found in 15% of 
the trials). The detailed risk of bias assessment for each trial and each domain can be seen in Appendix 4. 
 
Results of individual studies and data synthesis 
From the 20 unique trials (22 papers) that were included in the systematic review, three reported incomplete data and 
therefore could not be included in a meta-analysis (Figure 1) and although the authors were contacted, we took no 
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response. The quantitative results of individual studies and the performed meta-analyses are presented in Table 2. In 
all instances the MD and the OR were used for continuous and binary outcomes, respectively, with the exception of 
the tooth fluorescence outcome. Included studies that assessed tooth fluorescence used either QLF or laser fluorescence 
methods and therefore the Standardized Mean Difference (SMD) was used to pool these two measures together, while 
a post hoc sensitivity analysis was conducted to check the robustness of this choice. In cases of original trials that 
report results at baseline and at a following timepoint, we converted these into treatment-induced increments at the 
longest follow-up (after-treatment minus before-treatment). The needed pre-post correlation was calculated from the 
trial of Wilmot (35), which was the only one that provided raw data in the published paper. In almost all instances the 
included trials compared various interventions with a control/placebo group. The only exception is the trial of 
Andersson et al. (36) that compared head-on-head two interventions and its results are provided separately in Table 2. 
For all other cases, multiple trial arms were pooled within a trial before being compared to the control group to avoid 
double-counting of the control patients (21). 
As far as efficacy is concernced, statistically significant overall improvements were found between 
intervention and control groups for various optical outcomes of tooth color according to CIE L*a*b color space, which 
is a color-opponent space with the dimension L for lightness and a and b as the color-opponent dimensions. Additinally, 
statistically significant improvements after treatment were found for the clinical evaluation of WSLs either with the 
International Caries Detection and Assessment System II (ICDAS II) or other criteria. No adverse effects of 
interventions for post-orthodontic WSLs, apart from a single case of nausea after a patient swallowed a small portion 
of a fluoride varnish, reported from He et al. (37), which lasted for a day. However, the vast majority of comparisons 
were informed from a single trial. 
 
Risk of bias across studies 
Meta-analyses of at least three studies could be performed in just three instances: the outcomes of lesion area (Fig. 3), 
lesion fluorescence (Fig. 4), and clinical assessment of the lesion’s improvement (Table 2); these were chosen as the 
review’s main outcomes to be included in the Summary of Findings Table according to the GRADE approach (Table 
3; Appendix 5). The overall quality of evidence was judged as low to moderate for the three outcomes, with the main 
reasons for downgrading being either inconsistency (due to heterogeneity) or imprecision (due to inadequate sample 
sizes). 
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Additional analyses 
Subgroup analyses were conducted in order to determine the efficacy of every intervention separately (Appendix 6). 
As can be seen, considerable differences in the efficacy of the various treatments were found for the improvement in 
both lesion area and enamel fluorescence, which were also statistically significant according to the mixed-effect 
subgroup analysis. The bioactive glass toothpaste, the CPP-ACP cream with fluoride, and the fluoride varnish seemed 
to be the most effective in reducing the lesions’ area (Appendix 7). On the other side, the fluoridated chewing sticks 
(miswaks), the fluoride varnish, and the fluoride film (an acidulated sodium fluoride film that is applied and molds on 
the teeth) seemed to be the most viable intervention to increase the enamel’s fluorescence (Appendix 8). 
The follow-up duration after administration of the treatment to the WSLs was not stignificantly associated 
with the intervention’s effect on the lesion’s area. However, significantly greater improvements of the enamel’s 
fluorescence were seen with greater follow-ups (P=0.032; Appendix 9). This might not directly be associated with the 
administered treatment and could possibly be attributed to the prolonged use of fluoride toothpaste during this period. 
The sensitivity analysis by excluding trials with high risk of bias indicated only minor difference in effect 
magnitude with consistent effect direction (Appendix 10). Overall, no statistically significantly differences were found, 
although this could also be attributed to the small sample size. Sensitivity analysis according to the mean number of 
WSLs per patient indicated that as the mean number of WSLs per patient increased, the improvement seemed to 
decrease significantly (Appendix 10-11). Although this should be interpreted with great caution, this might indicate 
that not all WSLs respond the same to the intervention and trials that assess few WSLs per patient tend to include only 
those that responded well. Additionally, the sensitivity analysis according to the measurement method for enamel 
fluorescence indicated that considerable differences existed between QLF and DIAGNOdent, where the latter yielded 
both greater and more imprecise values (Appendix 10 & 12). 
Finally, a sensitivity analysis was performed in order to improve the overall quality of evidence according to 
GRADE. As the problem of imprecision could not be addressed, the issue of heterogeneity was addressed by breaking 
down the two heterogeneous outcomes of lesion area and enamel fluorescence in their subgroups according to 
intervention (Appendix 13). According to this analysis, the use of either fluoride varnish or fluoride film seemed to be 
the most attractive choice in terms of both outcomes. Even though this did not have the largest effect that was seen 
among trials, it was still the only choice that is supported by high quality of evidence and is still statistically significant. 
Therefore, it might be preferable to base clinical decisions for the outcomes of improvement of lesion area and enamel 
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fluorescence on the sensitivity analyses for each separate material rather than the main analyses, where all interventions 
all pooled, as the overall quality of evidence was poorer. 
 
Discussion 
Summary of evidence 
This systematic review included 20 randomized and trials and a total of 942 patients. Although some evidence exists 
on the clinical performance of various interventions for post-orthodontic WSLs, the majority of this evidence originates 
from small trials with unclear reporting or considerable limitations in their planning, conduct, and reporting. Despite 
the advances in orthodontic materials and techniques during the last decades, treating resistant post-orthodontic WSLs 
still remain a challenge. 
Overall, available interventions for WSLs provided a small, and possibly clinically irrelevant improvement 
of WSL in lesion area, enamel fluorescence, and clinical evaluation groups, compared to daily oral hygiene procedures. 
Both effects were not statistically significant (although close to), probably due to the small effects detected and the 
observed imprecision. 
However, a wide variety of interventions was used in the included studies. Some researchers (39) have warned 
against the use of high-fluoride materials to treat WSLs in esthetically-demanding labial tooth surfaces, as the quick 
surface hypermineralization arrests further demineralization, but also remineralization of WSLs. Although this might 
be preferable in posterior lesions, instant arrest of an anterior lesion might also carry the risk of staining by organic 
debris and a subtler remineralization with more natural means (i.e. through saliva and low-fluoride materials) might 
be associated with more esthetically-pleasing and stable results (40, 41). Interestingly, the results of the meta-analyses 
according to the different interventions used (Figures 5-6), and especially the results of the sensitivity analyses 
(Appendix 13), indicated that a monthly fluoride supplementation in the form of a fluoride varnish of a fluoride film 
was the most effective protocol to enhance the “natural” remineralization that takes place due to toothbrushing with a 
fluoride-containing dentifrice. It has long been known that fluoride inhibits mineral loss during acid dissolution, 
enhances mineralization of dental enamel, and might also increase the enamel’s resistance against demineralization 
(42–44). However, as He et al. (37) reported, interventions for WSLs mostly resulted in an improvement of the WSLs, 
while a complete healing of the WSL is seldom seen [in 2 of the 528 teeth included (37)]. The use of either a bioactive 
glass toothpaste or a fluoride-containing CPP-ACP cream was associated with above the average improvement in 
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lesion area, but as this originated from small trials with high risk of bias, caution is warranted by the interpretation of 
these findings and further confirmatory evidence is needed. 
The evaluation method for WSLs is of paramount importance to the accurate detection or measurement of 
lesions, and therefore to clinical research comparing various modalities. Measurement of the lesion’s area in the 
included trials was performed with either photographic evaluation or QLF and no significant difference between the 
two methods were found (Appendix 10; P=0.568), which indicates that the levels of validity, repeatability, and 
agreement between photographic measurements and QLF might be comparable (13, 35, 45, 46). 
On the other hand, this doesn’t seem to be the case for the assessment of the WSLs’ fluorescence compared 
to healthy enamel. Two evaluation methods were used in the included trials: a laser fluorescence method based on the 
red end of the electromagnetic spectrum with light wavelength 655 nm (DIAGNODent, KaVo, Germany) or 
Quantitative Light-Induced Fluorescence (QLF), which uses a blue light lamp with peak intensity of 370 nm. The 
results of the sensitivity analyses indicated trials using DIAGNOdent reported significantly greater improvements in 
fluorescence compared to trials using QLF (Appendix 10; P=0.036). Additionally, the readings regarding the 
fluorescence improvement in the non-treated WSL with DIAGNOdent were more inconsistent than those with QLF 
(average standard deviation in the control groups of the included trials of 4.01 and 2.55 for DIAGNOdent and QLF, 
respectively). This seems to be in agreement with in vitro evidence, where the two methods were compared to the gold 
standard of histopathology and transverse microradiography that indicates that QLF might be a better method to 
evaluate mineral loss in carious lesions in enamel (46–48). Although the SMD was used in the main meta-analyses, 
which alleviates part of the variability in measurements and enables pooling of the two methods, it might be prudent 
to suggest that future trials prefer the use of QLF to WSLs, due to its better validity and repeatability (45, 46). 
Most included trials had a small to modest follow-up of up to 6.5 months after treatment, which might have 
an impact on the observed results. Existing studies indicate that a “natural” improvement of WSLs takes place post-
debond, which is more pronounced in the first 6 months (9, 13), but continues up to the 12th month, and extends up to 
the second year post-debond (9). Indeed, meta-regression analysis indicated that the trials’ follow-up period was 
significantly associated with the improvement of tooth fluorescence (P<0.05). Therefore, trials with extended follow-
up periods might be preferable in order to investigate the complete healing of post-orthodontic WSLs. 
 
Strengths and limitations 
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The strengths of this systematic review include it’s a priori registration in PROSPERO (49), the extensive unrestricted 
literature search, the use of robust methodology pertaining to the qualitative and quantitative synthesis of data (50), 
the exclusion of biased study designs (51), transparent reporting of quantitative data for all outcomes from included 
studies, assessment of the quality of evidence with the GRADE approach (18), and the use of sensitivity analyses to 
check the robustness of the results to the risk of bias. However, some limitations are also present in this study. First 
and foremost, this systematic review included mostly small randomized trials, which can influence the results of the 
meta-analyses (52). Furthermore, despite our attempts (Appendix 14), no clarifications or additional outcome data 
could be obtained from many authors of included studies, many of which used possibly inappropriate analyses methods 
that disregarded the correlation of multiple WSLs within each patient. Such trials need to take clustering into account 
during the planning, conduct, and analysis stage (53), and failure to do so might impact their results (54). Finally, the 
limited number of included trials precluded robust assessments of heterogeneity, subgroup analyses, small-study 
effects, and reporting biases for most of the outcomes (Appendix 15).  
 
Recommendations for clinical practice 
Based on available overall evidence, current interventions for WSL, supplemental to daily tooth-brushing with a 
fluoride dentifrice, seem to have only a modest, and possibly clinically irrelevant, added value to the improvement of 
WSLs (low quality evidence). Among the available treatments, the monthly use of a 22,600 ppm F fluoride varnish or 
a 5% NaF film seem to be the best viable protocols to augment daily use of a fluoride dentifrice in terms of both 
reducing the WSL area and to increasing its esthetic appearance (fluorescence; high quality of evidence). The treatment 
effects of a bioactive glass toothpaste or a CPP-ACP cream with fluoride seem promising, but high uncertainty exists 
due to risk of bias and therefore need to be supported by high quality evidence before they can be recommended. 
 
Recommendations for further research 
The inclusion of additional parallel randomized trials or split-mouth randomized trials is needed. These should 
preferably use QLF methods in the assessment of enamel demineralization instead of the DIAGNOdent method and 
follow WSLs treated after debonding for 1-2 years. Additionally, future trials should take into account clustering during 
the statistical analyses in order to robustly assess the efficacy of various interventions for post-orthodontic WSLs, 
especially in the long term. Furthermore, well-conducted trials are needed to robustly assess the efficacy of several 
interventions with limited evidence including CPP-ACP creams with fluoride, bioactive glass dentifrices, bleaching, 
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microabrasion, and resin infiltration. The addition of more future trials will also consolidate the network of available 
interventions, which at the present time is somewhat scarcely connected (Appendix 16). This will enable the ranking 
of all available treatments according to their efficacy through network meta-analysis, which is considered to provide 
the highest level of treatment to inform treatment guidelines (55). Finally, given the complex character of the research 
question and the multiple treatment groups, outcomes, timepoints, and the effect clustering can have on a trial’s 
conlusions, orthodontic researchers and journal editors are encouraged to support both the registration and the 
provision of widely publically available raw trial data to improve their credibility (56). 
 
Supplementary material 
Supplementary material is available at European Journal of Orthodontics online. 
 
Acknowledgements 
The authors would like to thank F. Garcia-Godoy (University of Tennessee Health Science Center, Memphis, USA) 
and C.J. Kleber (Indiana University–Purdue University Indianapolis, Indianapolis, USA) for providing additional 
information about their trials and D. Covell Jr. (Oregon Health & Science University, Oregon, USA) and Dr. V. 
Mollabashi (Hamadan University of Medical Sciences, Hamadan, Iran) for providing additional data. 
 
Conflicts of interest 
None. 
 References 
1. Gorelick, L., Geiger, A. and Gwinnett, A. (1982) Incidence of white spot formation after bonding and banding. 
American Journal of Orthodontics, 81, 93–98. 
2. Willmot, D.R. and Brook, A.H. (1999) The incidence of post-orthodontic demineralized enamel lesions in an 
orthodontic clinic. Journal of Dental Research, 78, 1049. 
3. Mizrahi, E. (1982) Enamel demineralization following orthodontic treatment. American Journal of Orthodontics 
and Dentofacial Orthopedics, 82, 62–67. 
4. Mizrahi, E. (1983) Surface distribution of enamel opacities following orthodontic treatment. American Journal 
of Orthodontics and Dentofacial Orthopedics, 84, 323–331. 
15 
5. Marcusson, A., Norevall, L.I. and Persson, M. (1997) White spot reduction when using glass ionomer cement 
for bonding in orthodontics: a longitudinal and comparative study. European Journal of Orthodontics, 19, 233–
42. 
6. Ogaard, B., Rolla, J. and Arends, J. (1998) Orthodontic appliances and enamel demineralization. Part 1. Lesion 
development. American Journal of Orthodontics and Dentofacial Orthopedics, 94, 68–73. 
7. Benson, P.E., Parkin, N., Dyer, F., Millett, D.T., Furness, S. and Germain, P. (2013) Fluorides for the prevention 
of early tooth decay (demineralised white lesions) during fixed brace treatment. Cochrane Database of 
Systematic Reviews, 12, CD003809. 
8. Papageorgiou, S.N., Gölz, L., Jäger, A., Eliades, T. and Bourauel, C. (2016) Lingual vs. labial fixed orthodontic 
appliances: systematic review and meta-analysis of treatment effects. European Journal of Oral Sciences, 124, 
105–18. 
9. Shungin, D., Olsson, A.I. and Persson, M. (2010) Orthodontic treatment-related white spot lesions: a 14-year 
prospective quantitative follow-up, including bonding material assessment. American Journal of Orthodontics 
and Dentofacial Orthopedics, 138, 136.e1–8. 
10. Rosenbloom, R.G. and Tinanoff, N. (1991) Salivary Streptococcus mutans levels in patients before, during, and 
after orthodontic treatment. American Journal of Orthodontics and Dentofacial Orthopedics, 100, 35–7. 
11. ten Cate, J.M. and Arends, J. (1980) Remineralization of artificial enamel lesions in vitro. III. A study of 
deposition mechanism. Caries Research, 14, 351–8. 
12. Mattousch, T.J., van der Veen, M.H. and Zentner, A. (2007) Caries lesions after orthodontic treatment followed 
by quantitative light-induced fluorescence: a 2-year follow-up. European Journal of Orthodontics, 29, 294–8. 
13. Willmot, D. (2008) White spot lesions after orthodontic treatment. Seminars in Orthodontics, 14, 209–219. 
14. Welbury, R.R. and Carter, N.E. (1993) The hydrochloric acid-pumice microabrasion technique in the treatment 
of postorthodontic decalcification. British Journal of Orthodontics, 20, 181–185. 
15. Chen, H., Liu, X., Dai, J., Jiang, Z., Guo, T. and Ding, Y. (2013) Effect of remineralizing agents on white spot 
lesions after orthodontic treatment: a systematic review. American Journal of Orthodontics and Dentofacial 
Orthopedics, 143, 376–382.e3. 
16. Sonesson, M., Bergstrand, F., Gizani, S. and Twetman, S. (2016) Management of post-orthodontic white spot 
lesions: an updated systematic review. European Journal of Orthodontics, [Epub ahead of print]. 
16 
17. Papageorgiou, S.N., Papadopoulos, M.A. and Athanasiou, A.E. (2011) Evaluation of methodology and quality 
characteristics of systematic reviews in orthodontics. Orthodontics and Craniofacial Research, 14, 116–137. 
18. Guyatt, G.H., Oxman, A.D., Schünemann, H.J., Tugwell, P. and Knottnerus, A. (2011) GRADE guidelines: a 
new series of articles in the Journal of Clinical Epidemiology. Journal of Clinical Epidemiology, 64, 380–382. 
19. IntHout, J., Ioannidis, J.P., Rovers, M.M. and Goeman, J.J. (2016) Plea for routinely presenting prediction 
intervals in meta-analysis. BMJ Open, 6, e010247. 
20. Shamseer, L., Moher, D., Clarke, M., Ghersi, D., Liberati, A., Petticrew, M., Shekelle, P. and Stewart, L.A.; 
PRISMA-P GROUP. (2015) Preferred reporting items for systematic review and meta-analysis protocols 
(PRISMA-P) 2015: elaboration and explanation. British Medical Journal, 349, g7647. 
21. Higgins, J.P.T. and Green, S. (2016) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 
[updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane-handbook.org (10 August 2016, date 
last accessed). 
22. Liberati, A., et al. (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies 
that evaluate health care interventions: explanation and elaboration. Journal of Clinical Epidemiology, 62, e1–
e34. 
23. DerSimonian, R. and Laird, N. (1986) Meta-analysis in clinical trials. Controlled Clinical Trials, 7, 177–188. 
24. Papageorgiou, S.N. (2014) Meta-analysis for orthodontists: Part I--How to choose effect measure and statistical 
model. Journal of Orthodontics, 41, 317–26. 
25. Higgins, J.P., Thompson, S.G., Deeks, J.J. and Altman, D.G. (2003) Measuring inconsistency in meta-analyses. 
British Medical Journal, 327, 557–560. 
26. Ioannidis, J.P., Patsopoulos, N.A. and Evangelou, E. (2007) Uncertainty in heterogeneity estimates in meta-
analyses. British Medical Journal, 335, 914–916. 
27. Orsini, N., Bottai, M., Higgins, J. and Buchan, I. (2006) Heterogi: Stata module to quantify heterogeneity in a 
meta-analysis. Statistical Software Components 2006. www.EconPapers.repec.org/ RePEc:boc:bocode:s449201 
(10 August 2016, date last accessed). 
28. Ioannidis, J.P. (2008) Interpretation of tests of heterogeneity and bias in meta-analysis. Journal of Evaluation in 
Clinical Practice, 14, 951–957. 
29. Norman, G.R., Sloan, J.A. and Wyrwich, K.W. (2003) Interpretation of changes in health-related quality of life: 
the remarkable universality of half a standard deviation. Medical Care, 41, 582–592. 
17 
30. Papageorgiou, S.N. (2014) Meta-analysis for orthodontists: Part II – is all that glitters gold? Journal of 
Orthodontics, 41, 327–336. 
31. Knapp, G. and Hartung, J. (2003) Improved tests for a random effects meta-regression with a single covariate. 
Statistics in Medicine, 22, 2693–2710. 
32. Egger, M., Davey Smith, G., Schneider, M. and Minder, C. (1997) Bias in meta-analysis detected by a simple, 
graphical test. British Medical Journal, 315, 629–634. 
33. Ekstrand, K.R., Ricketts, D.N. and Kidd, E.A. (1997) Reproducibility and accuracy of three methods for 
assessment of demineralization depth on the occlusal surface: an in vitro examination. Caries Research, 31, 
224–331. 
34. Andersson, A., Sköld-Larsson, K., Hallgren, A., Petersson, L.G. and Twetman, S. (2004) Measurement of 
enamel lesion regression with a laser fluorescence device (DIAGNOdent): a pilot study. Orthodontics, 1, 201–
205. 
35. Willmot, D.R. (2004) White lesions after orthodontic treatment: does low fluoride make a difference? Journal of 
orthodontics, 31, 235–42. 
36. Andersson, A., Skold-Larsson, K., Hallgren, A., Petersson, L.G. and Twetman, S. (2007) Effect of a dental 
cream containing amorphous cream phosphate complexes on white spot lesion regression assessed by laser 
fluorescence. Oral Health & Preventive Dentistry, 5, 229–33. 
37. He, T., Li, X., Dong, Y., Zhang, N., Zhong, Y., Yin, W. and Hu, D. (2016) Comparative assessment of fluoride 
varnish and fluoride film for remineralization of postorthodontic white spot lesions in adolescents and adults 
over a 6-month period: A single-center, randomized controlled clinical trial. American Journal of Orthodontics 
and Dentofacial Orthopedics, 149, 810–9. 
38. Bailey, D.L., Adams, G.G., Tsao, C.E., Hyslop, A., Escobar, K., Manton DJ, Reynolds EC and Morgan MV. 
(2009) Regression of post-orthodontic lesions by a remineralizing cream. Journal of Dental Research, 88, 1148–
53. 
39. Ogaard, B., Rolla, G., Arends, J. and ten Cate, J.M. (1988) Orthodontic appliances and enamel demineralization. 
Part 2: prevention and treatment of lesions. American Journal of Orthodontics and Dentofacial Orthopedics, 93, 
123–128. 
40. O’Reilly, M.M. and Featherstone, J.D.B. (1987) Demineralization and remineralization around orthodontic 
appliances: an in vivo study. American Journal of Orthodontics and Dentofacial Orthopedics, 92, 33–40. 
18 
41. Lee Linton, J. (1996) Quantitative measurements of remineralization of incipient caries. American Journal of 
Orthodontics and Dentofacial Orthopedics, 104, 590–597. 
42. Basdra, E.K., Huber, H. and Komposch, G. (1996) Fluoride released from orthodontic bonding agents alters the 
enamel surface and inhibits enamel demineralization in vitro. American Journal of Orthodontics and 
Dentofacial Orthopedics, 109, 466–72. 
43. Attin, T., Kielbassa, A.M., Schwanenberg, M. and Hellwig, E. (1997) Effect of fluoride treatment on 
remineralization of bleached enamel. Journal of Oral Rehabilitation, 24, 282–6. 
44. McNeill, C.J., Wiltshire, W.A., Dawes, C. and Lavelle, C.L. (2001) Fluoride release from new light-cured 
orthodontic bonding agents. American Journal of Orthodontics and Dentofacial Orthopedics, 120, 392–7. 
45. Benson, P.E., Pender, N. and Higham, S.M. (2003) Quantifying enamel demineralization from teeth with 
orthodontic brackets—a comparison of two methods. Part 1: repeatability and agreement. European Journal of 
Orthodontics, 25, 149–58. 
46. Benson, P.E., Pender, N. and Higham, S.M. (2003) Quantifying enamel demineralization from teeth with 
orthodontic brackets--a comparison of two methods. Part 2: validity. European Journal of Orthodontics, 25, 
159–65. 
47. Pretty, I.A., Pender, N., Edgar, W.M. and Higham, S.M. (2003) The in vitro detection of early enamel de- and 
re-mineralization adjacent to bonded orthodontic cleats using quantitative light-induced fluorescence. European 
Journal of Orthodontics, 25, 217–23. 
48. Aljehani, A., Tranaeus, S., Forsberg, C.M., Angmar-Månsson, B. and Shi, XQ. (2004) In vitro quantification of 
white spot enamel lesions adjacent to fixed orthodontic appliances using quantitative light-induced fluorescence 
and DIAGNOdent. Acta Odontologica Scandinavica, 62, 313–8. 
49. Booth, A., Clarke, M., Ghersi, D., Moher, D., Petticrew, M. and Stewart, L. (2011) An international registry of 
systematic-review protocols. Lancet, 377, 108–9. 
50. Papageorgiou, S.N., Papadopoulos, M.A. and Athanasiou, A.E. (2014) Reporting characteristics of meta-
analyses in orthodontics: methodological assessment and statistical recommendations. European Journal of 
Orthodontics, 2014, 36, 74–85. 
51. Papageorgiou, S.N., Xavier, G.M. and Cobourne, M.T. (2015) Basic study design influences the results of 
orthodontic clinical investigations. Journal of Clinical Epidemiology, 68, 1512–22. 
19 
52. Cappelleri, J.C., Ioannidis, J.P., Schmid, C.H., de Ferranti, S.D., Aubert, M., Chalmers, T.C. and Lau, J. (1996) 
Large trials vs meta-analysis of smaller trials: how do their results compare? JAMA, 276, 1332–8. 
53. Pandis, N., Walsh, T., Polychronopoulou, A., Katsaros, C. and Eliades, T. (2013) Split-mouth designs in 
orthodontics: an overview with applications to orthodontic clinical trials. European Journal of Orthodontics, 35, 
783–9. 
54. Koletsi, D., Pandis, N., Polychronopoulou, A. and Eliades, T. (2012) Does published orthodontic research 
account for clustering effects during statistical data analysis? European Journal of Orthodontics, 34, 287–92. 
55. Leucht, S., Chaimani, A., Cipriani, A.S., Davis, J.M., Furukawa, T.A. and Salanti, G. (2016) Network meta-
analyses should be the highest level of evidence in treatment guidelines. European Archives of Psychiatry and 
Clinical Neuroscience, [Epub ahead of print]. 
56. Ioannidis, J.P. (2014) How to make more published research true. PLoS Medicine, 11, e1001747. 
  
20 
Figure legends 
Figure 1. Flowdiagram for the identification and selection of studies in this systematic review. 
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Figure 2. Summary of the risk of bias of the trials included in this systematic review. 
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Figure 3. Contour-enhanced forest plot of the treatment effects on white spot lesion area. Color contours indicate increasing effect magnitude from the 
middle to the ends of the forest plot: small effects (white); moderate effects (light grey); large effects (dark grey); and very large effects (darker grey). 
Mos, months of follow-up; MD; mean difference; CI, confidence interval; comb, combined trial arms; and PrI, predictive interval. Studies on the left and 
the right side of the middle line favor the intervention and the control group, respectively. 
 
. 
  
23 
Figure 4. Contour-enhanced forest plot of the treatment effects on white spot lesion fluorescence. Color contours indicate increasing effect magnitude 
from the middle to the ends of the forest plot: small effects (white); moderate effects (light grey); large effects (dark grey); and very large effects (darker 
grey). Mos, months of follow-up; Method, method of outcome measurement; SMD; standardized mean difference; CI, confidence interval; comb, combined 
trial arms; DD, DIAGNOdent; QLF, quantitative light-induced fluorescence; and PrI, predictive interval. Studies on the left and the right side of the middle 
line favor the intervention and the control group, respectively. 
 
 
.
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Tables 
Table 1. Characteristics of the included trials. 
AA Trial Design 
Patients 
(M/F) 
Mean 
age (yr) 
Debond-
Interventi
on period 
WSLs/pat Intervention Other F sources Follow-up Outcome Conflict of interest 
1 Agarwal 2013 
RCTSM; 
university; 
India 
31 (NR) 19.6 Directly (≥4) 
G1: F-TP (1450 ppm F) 
G2: Non- F-TP 
- 8 wks (Clin) ICDAS II None 
2 Aljehani 2006 
RCTPAR; 
hospital; 
Saudia Arabia 
12 (NR) (13-17) 
NR 
(recently) 
10.6  
OHI plus: 
G1: PTC/ 3mos 
G2: Control 
TP (provided; 
1500 ppm F) 
3/ 6/ 9/ 12 
mos 
-(Clin) Ekstrand 
et al. (33) 
criteria (mod.) 
-Fluoresence 
(DD) 
Not declared 
3 
Andersson 
2007 
RCTPAR; 
hospital; 
Sweden 
26 
(13/13) 
14.6 Directly 5.1  
G1: CPP-ACP cream (first 3mos) / 
F-TP (1000-1100 ppm F; next 
3mos) 
G2: F-TP (1000-1100 ppm F) & F-
MR (0.05% NaF); both 6mos 
- 
1/ 3/ 6/ 12 
mos 
-(Clin) 
Andersson et al. 
(34) criteria 
-Fluoresence 
(DD) 
Not declared 
4 
Baeshen 
2011 
RCTPAR; 
hospital; Saudi 
Arabia 
37 
(11/26) 
17.2 Directly 7.9  
G1: F-chewing sticks “Miswaks 
(0.5% NaF) 
G2: non-F-Miswaks 
TP (instructed; 
1450 ppm F) 
2/ 4/ 6 
wks 
-(Clin) ICDAS II 
-Fluoresence 
(DD) 
None 
5 Bailey 2009 
RCTPAR; 
private 
practice; 
Australia 
45 
(22/23) 
15.5 Directly 9.1  
G1: CPP-ACP cream 
G2: Placebo cream 
-TP (instructed; 
1000 ppm F) 
-MR (900 ppm F)/ 
4wks 
4/ 8/ 12 
wks 
(Clin) ICDAS II 
Not declared; trial 
partly funded by a 
company. 
6 
Beerens 
2010$ 
RCTPAR; 
university; 
Netherlands 
54 
(23/31) 
15.5 Directly 7.9 
G1: CPP-ACP cream (900 ppm F) 
G2: Control (non- F-TP) 
TP (instructed; NR 
ppm F) 
6/ 12 wks QLF imaging 
Not declared; 
material donation. 
7 
Bröchner 
2011 
RCTPAR; 
university; 
Denmark 
60 
(27/33) 
15.2 NR 6.5 
G1: CPP-ACP cream 
G2: Control 
TP (provided; 
1100 ppm F) 
4/ 12 wks 
-(Clin) Gorelick 
et al. (1) criteria 
-QLF imaging 
None; partial 
funding and 
material donation 
from a company. 
8 Clark 2011 
RCTPAR; 
university; 
USA 
12 (5/7) (12-20) 1-2 wks 3.9 
G1: CPP-ACP cream (900 ppm F) 
G2: Control 
TP (provided; NR 
ppm F) 
3/ 6/ 9/ 12 
wks 
-(Clin) 
Photograph 
-QLF imaging 
Not declared 
9 Cronan 2012 
RCTSM; 
university; 
USA 
11 (7/4) 16.5 
6 mos – 
14 yrs 
45.4 
G1: Resin infiltrant 
G2: Control 
- 4/ 6 wks -EDI (mod.) Not declared 
10 Du 2012 
RCTPAR; 
university; 
China 
96 
(31/65) 
16.6 Directly 2.2 
G1: F varnish (22,600 ppm F)/ mo 
G2: Saline solution/ mo 
TP (instructed; F 
concentration NR) 
3/ 6 mos 
Fluoresence 
(DD) 
None 
11 
Eckstein 
2013; Knösel 
2013; 
Eckstein 2015 
RCTSM; 
university; 
Germany 
21 
(10/11) 
15.5 1-12 mos 11.0 
G1: Resin infiltrant 
G2: Control 
TP (provided; 
1400 ppm F) 
1 d/ 1/ 4 
wks/ 3/ 6 
mos 
CIE L*a*b 
values 
Not declared; 
grant and 
intervention 
material donation 
from a company. 
25 
12 He 2016 
RCTPAR; 
university; 
China 
211 
(94/117) 
16.9 
NR 
(recently) 
2.5 
G1: F varnish (22,600 ppm F)/ mo 
G2: F film (5% NaF)/ mo 
G3: Placebo toothpaste/ mo 
TP (provided; F 
concentration NR) 
3/ 6 mos QLF imaging None 
13 Huang 2013 
RCTPAR; 
private 
practice; USA 
115 
(56/59) 
14.4 ≤2 mos 3.2 
G1: CPP-ACP cream (900 ppm F) 
G2: F varnish (22,600 ppm F)/mo 
G3: Control 
TP (provided; 
1100 ppm F) 
8 wks 
-(Clin) 
Photograph 
-Patient 
satisfaction 
(VAS) 
None 
14 
Jumanca 
2012 
RCTPAR; 
university; 
Romania 
62 (NR) (13-22) Directly (≥2) 
G1: Resin infiltrant 
G2: F varnish (22,600 ppm F)/mo 
G3: Control 
- 3/ 6 mos 
Fluoresence 
(DD) 
Not declared 
15 Knösel 2007 
RCTPAR; 
university; 
Germany 
19 (NR) NR <3 mos 3.7 
G1: External bleaching (1 x in-
office/ 1 x at-home) 
G2: Control 
F gel (instructed; 
12,500 ppm F) 
2/ 4 wks 
-CIE L*a*b 
values  
-Patient 
satisfaction 
(VAS) 
Not declared 
16 
Miresmaeili 
2012 
RCTPAR; 
university; Iran 
20 (4/16) NR NR 3.1 
G1: F varnish (22,600 ppm F)/mo 
G2: Control 
- 4 mos 
(Clin) 
Photograph 
Not declared 
17 Seibold 2015 
RCTPAR; 
university; 
Germany 
39 
(17/22) 
15.3 Directly (≥1) 
G1: F gel (12,500 ppm F)/wk 
G2: Placebo gel/wk 
TP (provided; 
1400 ppm F) 
1/ 2/ 6/ 
12/ 24 
wks 
-(Clin) 
Photograph 
-CIE L*a*b 
values  
-ICDAS II 
- Gorelick et al. 
(1) criteria 
-DMFT index 
Not declared; 
sponsored from 
company. 
18 
Senestraro 
2013 
RCTPAR; 
university; 
USA 
20 (NR) 16.6 12.3 mos 3.3 
G1: Resin infiltrant 
G2: Control 
TP (provided; F 
concentration NR) 
8 wks 
(Clin) 
Photograph & 
VAS 
None; intervention 
material donated 
from a company. 
19 Shell 2012 
RCTPAR; 
university; 
USA 
30 
(12/18) 
16.1 
NR 
(recently) 
5.9 
G1: CPP-ACP cream 
G2: CPP-ACP cream (900 ppm F) 
G3: CPP-ACP cream (900 ppm F) 
(in-office & at-home) 
G4: BA TP (5000 ppm F) 
G5: Control 
TP (provided; 
1100 ppm F) 
3 mos 
-(Clin) 
Photograph 
-QLF imaging 
Not declared 
20 Willmot 2004 
RCTPAR; 
university; UK 
21 (6/15) 15.8 Directly 
(max. 4 
selected) 
G1: F MR (50 pppm) 
G2: Placebo MR 
None (non-F 
toothpaste 
provided) 
12/ 26 
wks 
(Clin) 
Photograph 
Not declared 
M, male; F, female; yr, year; WSL, white spot lesion; pat, patient; CoI, conflict of interest; RCTSM, split mouth randomized controlled trial; NR, not reported; G, group; F, 
fluoride; TP, toothpaste; ppm, parts per million; wk, week; Clin, clinical evaluation; ICDAS II, International Caries Detection and Assessment System II criteria; RCTPAR, 
parallel randomized controlled trial; OHI, oral hygiene instructions; PTC, professional tooth cleaning; mo, month; DD, DIAGNOdent; CPP-ACP, casein phosphopeptide-
stabilized amorphous calcium phosphate; NaF; sodium fluoride; MR, mouthrinse; QLF, quantitative light-induced fluorescence; USA, United States of America; EDI, 
Enamel Decalcification Index; CIE L*a*b, Commission internationale de l’ e´ clairage Lab color space; VAS, visual analogue scale; DMFT, decayed missing filled teeth; 
BA, bioactive glass; UK, united kingdom. 
$, additional outcomes not pertaining to WSL treatment directly are not included here. 
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Table 2. Results of individual studies and meta-analyses on all outcomes reported by the included studies. 
Continuous outcomes 
     Comparison n MD 95% CI P tau2 I2 95% UI 95% PrI 
  Assessment VAS (expert) Tx1,2 vs Ctr 1* -2.53 -11.68,6.62 0.588 - - - - 
  Assessment VAS (layperson) Tx1,2 vs Ctr 1* 3.86 -4.10,11.82 0.342 - - - - 
  Assessment VAS (objective) Tx1,2 vs Ctr 1* -0.71 -7.12,5.70 0.828 - - - - 
  Assessment VAS (self-assesment) Tx1,2 vs Ctr 1* 0.37 -7.22,7.96 0.924 - - - - 
  CIE: a (WSL) Tx3 vs Ctr 1 -0.36 -0.77,0.05 0.086         
  CIE: a (WSL) - adjusted estimate Tx4 vs Ctr 1 -1.45 -2.20,-0.71 <0.001         
  CIE: a (WSL/SAE) - adjusted estimate Tx4 vs Ctr 1 -1.46 -2.03,-0.89 <0.001         
  CIE: b (WSL) Tx3 vs Ctr 1 -5.87 -7.26,-4.48 <0.001         
  CIE: b (WSL) - adjusted estimate Tx4 vs Ctr 1 -5.63 -7.51,-3.75 <0.001         
  CIE: b (WSL/SAE) - adjusted estimate Tx4 vs Ctr 1 -3.65 -5.45,-1.85 <0.001         
  CIE: ΔE (WSL/SAE) - adjusted estimate Tx4 vs Ctr 1 2.60 1.44,3.76 <0.001         
  CIE: L (WSL in %) Tx4 vs Ctr 1 -4.50 -29.96,20.96 0.729         
  CIE: L (WSL) Tx3,4 vs Ctr 2 1.41 -2.16,4.97 0.439 5.966 90 - - 
  CIE: L (WSL) - adjusted estimate Tx4 vs Ctr 1 2.19 0.99,3.39 <0.001         
  CIE: L (WSL/SAE) - adjusted estimate Tx4 vs Ctr 1 1.89 0.97,2.81 <0.001         
  ΔQ (QLF) Tx2,5 vs Ctr 1* 12.99 7.69,18.29 <0.001 - - - - 
  Fluoresence (QLF/DD)# Tx1,2,5-7,9,10 vs Ctr 8* -0.35 -0.75,0.05 0.085 0.280 91 85,94 -1.74,1.04 
  ICDAS II Tx9,10 vs Ctr 1* -0.66 -0.92,-0.40 <0.001 - - - - 
  IFL (QLF) Tx7 vs Ctr 1 6.31 -6.40,19.02 0.331 - - - - 
  WSL area Tx1,2,5-8 vs Ctr 6* -0.48 -.98,0.01 0.056 0.235 87 71,92 -2.00,1.04 
 WSL area/ tooth area in % Tx2 vs Ctr 1 -0.66 -2.83,1.51 0.551     
                      
  Fluoresence (QLF) Tx7 vs Tx11 1 0.00 -1.92,1.92 1.000 - - - - 
                      
Binary outcomes 
   Outcome  Comparison  n OR 95% CI P tau2 I2 95% UI 95% PrI 
  ΔE (WSL)>3.0 Tx3 vs Ctr 1 4.42 1.53,12.78 0.006         
  ΔE (WSL)>3.7 Tx3 vs Ctr 1 7.84 2.64,23.26 <0.001         
  ΔE (WSL/Ctr)>3.0 Tx3 vs Ctr 1 0.06 0.01,0.28 <0.001         
  ΔE (WSL/Ctr)>3.7 Tx3 vs Ctr 1 0.83 0.34,2.00 0.673         
  DMFT>0 Tx12 vs Ctr 1 0.67 0.18,2.46 0.543         
  Greater improvement than the control Tx4 vs Ctr 1 2.46 1.94,3.11 <0.001         
  Invisible /regressed WSLs Tx7,12 vs Ctr 3 0.97 0.60,1.56 0.893 0.069 38 0,82 - 
  Invisible WSLs Tx7 vs Ctr 2 0.79 0.53,1.18 0.247 0 0 - - 
  Nausea Tx2,5 vs Ctr 1* 2.43 0.09,67.57 0.601         
  Regressed WSLs Tx7 vs Ctr 1 1.67 0.81,3.44 0.168         
  Regressed WSLs (severe) Tx7 vs Ctr 1 2.34 1.07,5.12 0.034         
                      
  Invisible WSLs Tx8 vs Tx7 1 0.16 0.08,0.35 <0.001         
N, number of included studies; MD, mean difference; CI, confidence interval; UI, uncertainty interval (confidence interval for the I2); PrI, predictive 
interval (confidence interval integrating the identified heterogeneity among studies, in order to predict the possible effects in a future study); VAS, 
visual analogue scale; Tx, treatment (1-CPP-ACP & F; 2-F varnish; 3-Bleaching; 4-Resin infiltrant; 5-F film; 6-BG toothpaste; 7-CPP-ACP; 8-F 
mouthrinse; 9-F miswak; 10-Non-F miswak; 11-F toothpaste; 12-F gel); Ctr, control; CIE, Commission Internationale de l'Eclairage; WSL, white spot 
lesion; SAE, sound adjacent enamel; QLF, Quantitative light-induced fluorescence; DD, DIAGNOdent; ICDAS II, International Caries Detection and 
Assessment System II; OR, odds ratio; DMFT, decayed missing filled tooth index. 
*multiple trial arms with different interventions for WSL have been pooled together. 
#The Standardized Mean Difference is used instead of the Mean Difference, to account for differences in the two fluorescence measurements. 
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Table 3. GRADE summary of findings table for the main outcomes of the systematic review 
Patients: having at least one white spot lesion on the teeth after orthodontic treatment 
Settings: university clinics (China, Denmark, Germany, Netherlands, Romania, UK, USA), hospital (Saudi Arabia), and private practice (Australia) 
Intervention: BG toothpaste, CPP-ACP, CPP-ACP & F, F film, F gel, F mouthrinse, F varnish, F miswak, non-F miswak 
Comparison: no treatment (regular oral hygiene procedures; most with F toothpaste) 
Outcomes 
Illustrative comparative effects (95% CI) Patients 
(trials) 
GRADE* Effect 
Control Intervention 
 Assumed change† Corresponding change †    
Lesion area; (1.0-6.0 months) 
Lesion shrinkage of 0.37 mm2 
for the lesions in the control 
groups (range 1.92 mm2 
shrinkage to 0.48 mm2 
enlargement). 
The lesions shrink by 0.48 mm2 more in 
the intervention groups (95% CI: 0.98 
mm2 more to 0.01 mm2 less) than in the 
control groups. 
388 (6) 
⊕⊕⊝⊝a,b 
Low 
MD=-0.48 (-
0.98,0.01); 
P>0.05 
 Assumed change† Corresponding change    
Lesion fluorescence; (1.0-6.5 
months) 
The enamel fluorescence 
increases by 1.07% in the 
control groups (range 0.80% 
to 3.67% increase). 
The enamel fluorescence increases by 
0.88% more in the intervention groups 
(1.88% more to 0.13% less) than in the 
control groups. 
562 (8) 
⊕⊕⊝⊝a,b 
Low 
SMD=-0.35 (-
0.75,0.05); 
P>0.05 
 
Assumed risk per 1000 
lesions† 
Corresponding risk per 1000 lesions    
Improvement/regression of the 
lesion’s clinical assessment (3.0-
6.0 months) 
587 lesions per 1000 regress 
in the control groups. 
17 lesions fewer per 1000 (235 less to 
329 more) regress compared to the 
intervention groups. 
144 (3) 
⊕⊕⊕⊝b 
moderate 
OR=0.97 
(0.60,1.56); 
P>0.05 
BG, bioactive glass; CPP-ACP, casein phosphopeptide-stabilized amorphous calcium phosphate; F, fluoride; CI, confidence interval; MD, mean difference; 
SMD, standardized mean difference; OR, odds ratio. 
†Assumed changes and risks adopted from the randomized trials of He et al. (37) and Bailey et al. (38) , respectively, which were judged to be the most robust. 
*All GRADE scores start from high, due to the inclusion of randomized trials. 
a Downgraded by one for heterogeneity. 
b Downgraded by one for imprecision. 
 
 Supplementary material 
Interventions for orthodontically-induced white spot lesions: a systematic review and meta-analysis 
Supplementary material 1. Inclusion/exclusion criteria for this systematic review (as initially planned in the protocol; the included outcomes were 
reviewed post hoc). 
Domain Inclusion Exclusion 
Participants  Human patients 
 Patients of any age/sex/ethnicity with at least one white spot 
lesion on the labial or lingual surface of the teeth induced by 
a previous treatment with orthodontic appliances 
 Animal studies 
 Interventions  Any treatment - 
Comparisons  No treatment 
 Any other kind of treatment 
- 
Outcome  (primary): color difference (WSL vs adjacent sound enamel) 
between the treatment and the control groups 
 Segregated tooth color parameters L, a, b 
 Lesion severity 
 Lesion transition (progression, stability or regression) 
 Lesion depth 
 Lesion area 
 Integrated fluorescence loss 
- 
Study design  Randomized controlled trials (parallel or clustered)  
 Quasi-randomized controlled trials (parallel or clustered) 
 Non-randomized prospective or retrospective studies 
 Case reports/ case series 
 Non-clinical studies (in vitro, ex vivo, in silico, etc) 
 Systematic reviews (after checked for studies) 
  
  
 Supplementary material 2. Literature databases searched with search strategy and yield (last search May 9, 2016). 
Database Site Search strategy Limit Hits 
PubMed http://www.ncbi.nlm.nih.gov/pubmed/ 
("fixed appliance" OR orthodon* OR "fixed orthodontic" OR bracket* OR 
multibracket) AND (reminerali* OR deminerali* OR decalcif* OR "white spot" OR 
"white spot lesion" OR "enamel" OR enamel surface* "caries") 
Randomized 
Controlled Trial; 
Humans 
86 
Cochrane Library 
(CDSR) 
http://onlinelibrary.wiley.com/cochranelibrary/search/ 
("fixed appliance" OR orthodon* OR "fixed orthodontic" OR bracket* OR 
multibracket) AND (reminerali* OR deminerali* OR decalcif* OR "white spot" OR 
"white spot lesion" OR "enamel" OR enamel surface* "caries") 
- 6 
Cochrane Library 
(DARE) 
http://onlinelibrary.wiley.com/cochranelibrary/search/ 
("fixed appliance" OR orthodon* OR "fixed orthodontic" OR bracket* OR 
multibracket) AND (reminerali* OR deminerali* OR decalcif* OR "white spot" OR 
"white spot lesion" OR "enamel" OR enamel surface* "caries") 
- 6 
Cochrane Library 
(CENTRAL) 
http://onlinelibrary.wiley.com/cochranelibrary/search/ 
("fixed appliance" OR orthodon* OR "fixed orthodontic" OR bracket* OR 
multibracket) AND (reminerali* OR deminerali* OR decalcif* OR "white spot" OR 
"white spot lesion" OR "enamel" OR enamel surface* "caries") AND random* 
- 223 
Virtual Health Library http://pesquisa.bvsalud.org/portal/advanced/?lang=en 
("fixed appliance" OR orthodon* OR "fixed orthodontic" OR bracket* OR 
multibracket) AND (reminerali* OR deminerali* OR decalcif* OR "white spot" OR 
"white spot lesion" OR "enamel" OR enamel surface* "caries") AND random* 
- 9 
Scopus http://www.scopus.com/ 
("fixed appliance" OR orthodon* OR "fixed orthodontic" OR bracket* OR 
multibracket) AND (reminerali* OR deminerali* OR decalcif* OR "white spot" OR 
"white spot lesion" OR "enamel" OR enamel surface* "caries") AND random* 
Dentistry 67 
ISI Web of 
Knowledge 
http://apps.webofknowledge.com 
("fixed appliance" OR orthodon* OR "fixed orthodontic" OR bracket* OR 
multibracket) AND (reminerali* OR deminerali* OR decalcif* OR "white spot" OR 
"white spot lesion" OR "enamel" OR enamel surface* "caries") AND random* 
Research area: 
dentistry oral surgery 
medicine 
Document type: clinical 
trial 
192 
ClinicalTrials.gov https://clinicaltrials.gov/ 
("fixed appliance" OR orthodon* OR "fixed orthodontic" OR bracket* OR 
multibracket) AND (reminerali* OR deminerali* OR decalcif* OR "white spot" OR 
"white spot lesion" OR "enamel" OR enamel surface* "caries") 
- 11 
Overall 594 
 
 Supplementary material 3. List of included and excluded studies, with the corresponding reasons. 
No Paper 
 
Exclusion by title 
1 [No authors included] {NCT00268138} Elmex Gel Efficacy in Preventing White Spot Lesions. Status: Unknown. Exclude by title. 
2 
[No authors included] {NCT01082822} Periodontal Ligament Stem Cell Implantation in the Treatment of Periodontitis. 
Status: Unknown. 
Exclude by title. 
3 
Agrawal A, Shigli A. Comparison of six different methods of cleaning and preparing occlusal fissure surface before 
placement of pit and fissure sealant: an in vitro study. Journal of the Indian Society of Pedodontics and Preventive 
Dentistry. 2012;30(1):51-5. 
Exclude by title. 
4 
Al Shamsi A, Cunningham JL, Lamey PJ, Lynch E. Shear bond strength and residual adhesive after orthodontic 
bracket debonding. The Angle orthodontist 2006; (4):694-9. 
Exclude by title. 
5 
Al Shamsi AH, Cunningham JL, Lamey PJ, Lynch E. The effects of ozone gas application on shear bond strength of 
orthodontic brackets to enamel. American journal of dentistry 2008; (1):35-8. 
Exclude by title. 
6 
Al-Twaijri S, Viana G, Bedran-Russo AK. Effect of prophylactic pastes containing active ingredients on the enamel-
bracket bond strength of etch-and-rinse and self-etching systems. The Angle orthodontist 2011; (5):788-93. 
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Exclude by title. 
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11 
Bazargani F, Jacobson S, Lennartsson B. A comparative evaluation of lingual retainer failure bonded with or without 
liquid resin. The Angle orthodontist 2012; (1):84-7. 
Exclude by title. 
12 
Behnan SM, Arruda AO, Gonzalez-Cabezas C, Sohn W, Peters MC. In-vitro evaluation of various treatments to 
prevent demineralization next to orthodontic brackets. Am J Orthod Dentofac Orthop 2010;138(6):712 e1-7. 
Exclude by title. 
13 
Bishara SE, Ajlouni R, Oonsombat C, Laffoon J. Bonding orthodontic brackets to porcelain using different 
adhesives/enamel conditioners: a comparative study. World journal of orthodontics 2005; (1):17-24. 
Exclude by title. 
14 
Bishara SE, Damon PL, Olsen ME, Jakobsen JR. Effect of applying chlorhexidine antibacterial agent on the shear 
bond strength of orthodontic brackets. The Angle orthodontist 1996; (4):313-6. 
Exclude by title. 
15 
Bishara SE, Ostby AW, Ajlouni R, Laffoon JF, Warren JJ. Early shear bond strength of a one-step self-adhesive on 
orthodontic brackets. The Angle orthodontist 2006; (4):689-93. 
Exclude by title. 
16 
Bishara SE, Ostby AW, Laffoon J, Warren JJ. Enamel cracks and ceramic bracket failure during debonding in vitro. 
The Angle orthodontist 2008; (6):1078-83. 
Exclude by title. 
17 
Bishara SE, Ostby AW, Laffoon JF, Warren J. Shear bond strength comparison of two adhesive systems following 
thermocycling. A new self-etch primer and a resin-modified glass ionomer. The Angle orthodontist 2007; (2):337-41.  
Exclude by title. 
18 
Bishara SE, Ostby AW, Laffoon JF, Warren JJ. The effect of modifying the self-etchant bonding protocol on the shear 
bond strength of orthodontic brackets. The Angle orthodontist 2007; (3):504-8. 
Exclude by title. 
19 
Bishara SE, Soliman M, Ajlouni R, Laffoon J, Warren JJ. Waterline disinfectant effect on the shear bond strength of 
orthodontic brackets. The Angle orthodontist 2005; (6):1032-5. 
Exclude by title. 
20 
Bishara SE, Soliman M, Laffoon J, Warren JJ. Effect of antimicrobial monomer-containing adhesive on shear bond 
strength of orthodontic brackets. The Angle orthodontist 2005; (3):397-9. 
Exclude by title. 
21 
Bishara SE, Soliman M, Laffoon JF, Warren J. Shear bond strength of a new high fluoride release glass lonomer 
adhesive. Angle Orthod 2008;78(1):125-8. 
Exclude by title. 
22 
Bokle D, Munir H. An in vitro study of the effect of Pro Seal varnish on the shear bond strength of orthodontic brackets. 
World journal of orthodontics 2008; (2):141-6. 
Exclude by title. 
23 
Borges AFS, Simonato LE, Pascon FM, Kantowitz KR, Rontani RMP. Effects of resin luting agents and 1 percent 
NaOCl on the marginal fit of indirect composite restorations in primary teeth. J appl oral sci.19(5):455-61. 
Exclude by title. 
24 
Brackett MG, Dib A, Brackett WW, Estrada BE, Reyes AA. One-year clinical performance of a resin-modified glass 
ionomer and a resin composite restorative material in unprepared Class V restorations. Operative dentistry. 
2002;27(2):112-6. Epub 2002/04/05. 
Exclude by title. 
25 
Brackett WW, Dib A, Brackett MG, Reyes AA, Estrada BE. Two-year clinical performance of Class V resin-modified 
glass-lonomer and resin composite restorations. Operative dentistry. 2003;28(5):477-81. 
Exclude by title. 
26 
Cal-Neto JP, Carvalho F, Almeida RC, Miguel JA. Evaluation of a new self-etching primer on bracket bond strength in 
vitro. The Angle orthodontist 2006; (3):466-9. 
Exclude by title. 
27 
Cal-Neto JP, Miguel JA, Zanella E. Effect of a self-etching primer on shear bond strength of adhesive precoated 
brackets in vivo. The Angle orthodontist 2006; (1):127-31. 
Exclude by title. 
28 
Canay S, Kocadereli I, Ak"ca E. The effect of enamel air abrasion on the retention of bonded metallic orthodontic 
brackets. Am J Orthod Dentofac Orthop 2000; (1):15-9. 
Exclude by title. 
29 
Carstensen W. Effect of Reduction of Phosphoric-Acid Concentration on the Shear Bond Strength of Brackets. Am J 
Orthod Dentofac Orthop 1995;108(3):274-7. 
Exclude by title. 
30 
Cehreli SB, Sar C, Polat-Özsoy O, Unver B, Ozsoy S. Effects of a fluoride-containing casein phosphopeptide-
amorphous calcium phosphate complex on the shear bond strength of orthodontic brackets. Eur J Orthod 2012; 
(2):193-7. 
Exclude by title. 
31 
Chan DC, Browning WD, Frazier KB, Brackett MG. Clinical evaluation of the soft-start (pulse-delay) polymerization 
technique in Class I and II composite restorations. Operative dentistry. 2008;33(3):265-71. Epub 2008/05/29. 
Exclude by title. 
32 Chen DR, McGorray SP, Dolce C, Wheeler TT. Effect of early Class II treatment on the incidence of incisor trauma. Exclude by title. 
 Am J Orthod Dentofac Orthop 2011; (4):e155-60. 
33 
Cheng HY, Chen CH, Li CL, Tsai HH, Chou TH, Wang WN. Bond strength of orthodontic light-cured resin-modified 
glass ionomer cement. Eur J Orthod 2011; (2):180-4. 
Exclude by title. 
34 
Chicri RO, Sasaki RT, Carvalho AS, Nouer PR, Lima-Arsati YB. Effect of enamel pretreatment on shear bond strength 
of brackets bonded with resin-modified glass-ionomer cement. World journal of orthodontics 2010; (1):11-5. 
Exclude by title. 
35 
Cho JY, Lee DY, Lim YK. Shear bond strength of orthodontic adhesive to amalgam surface using light-cured resin. 
Korean Journal of Orthodontics 2005; (6):443-50. 
Exclude by title. 
36 
Compton AM, Meyers CE, Hondrum SO, Lorton L. Comparison of the shear bond strength of a light-cured glass 
ionomer and a chemically cured glass ionomer for use as an orthodontic bonding agent. Am J Orthod Dentofac Orthop 
1992; (2):138-44. 
Exclude by title. 
37 
Cucu M, Driessen CH, Ferreira PD. The influence of orthodontic bracket base diameter and mesh size on bond 
strength. SADJ : journal of the South African Dental Association = tydskrif van die Suid-Afrikaanse Tandheelkundige 
Vereniging 2002; (1):16-20. 
Exclude by title. 
38 
Danaei SM, Safavi A, Roeinpeikar SM, Oshagh M, Iranpour S, Omidkhoda M, et al. Ion release from orthodontic 
brackets in 3 mouthwashes: an in-vitro study. Am J Orthod Dentofac Orthop 2011; (6):730-4. 
Exclude by title. 
39 
Davari A, Yassaei S, Karandish M, Zarghami F. In vitro evaluation of microleakage under ceramic and metal brackets 
bonded with LED and plasma arc curing. The journal of contemporary dental practice 2012; (5):644-9. 
Exclude by title. 
40 
Davidovitch M, Efstathiou S, Sarne O, Vardimon AD. Skeletal and dental response to rapid maxillary expansion with 2- 
versus 4-band appliances. Am J Orthod Dentofac Orthop 2005; (4):483-92. 
Exclude by title. 
41 
Dubernard C, Raynal P, Tramini P. Comparative study of enamel adhesion between RelyX Unicem (3M), a self-
adhesive bonding agent, and the combination of MIP (3M), a hydrophilic adhesive, and Transbond Supreme Low 
Viscosity (3M), a traditional hydrophobic adhesive. International Orthodontics 2013; (3):247-61. 
Exclude by title. 
42 
El-Angbawi A, McIntyre Grant T, Fleming Padhraig S, Bearn David R. Non-surgical adjunctive interventions for 
accelerating tooth movement in patients undergoing fixed orthodontic treatment. Cochrane Database of Systematic 
Reviews 2015; (11). 
Exclude by title. 
43 
Farhadian N, Usefi Mashoof R, Khanizadeh S, Ghaderi E, Farhadian M, Miresmaeili A. Streptococcus mutans counts 
in patients wearing removable retainers with silver nanoparticles vs those wearing conventional retainers: A 
randomized clinical trial. Am J Orthod Dentofac Orthop 2016;149(2):155-60. 
Exclude by title. 
44 
Fitzgerald I, Bradley GT, Bosio JA, Hefti AF, Berzins DW. Bonding with self-etching primers-pumice or pre-etch? An in 
vitro study. Eur J Orthod 2012;34(2):257-61. 
Exclude by title. 
45 
Foley T, Aggarwal M, Hatibovic-Kofman S. A comparison of in vitro enamel demineralization potential of 3 orthodontic 
cements. Am J Orthod Dentofac Orthop 2002;121(5):526-30. 
Exclude by title. 
46 
Forsberg CM, Hagberg C. Shear bond strength of ceramic brackets with chemical or mechanical retention. British 
journal of orthodontics 1992; (3):183-9. 
Exclude by title. 
47 
Germeç D, Taner TU. Effects of extraction and nonextraction therapy with air-rotor stripping on facial esthetics in 
postadolescent borderline patients. Am J Orthod Dentofac Orthop 2008; (4):539-49. 
Exclude by title. 
48 
Gilpatrick RO, Johnson W, Moore D, Turner J. Pulpal response to dentin etched with 10% phosphoric acid. American 
journal of dentistry 1996; (3):125-9. 
Exclude by title. 
49 
Gomes P, Portugal J, Jardim L. Effect of high-powered LED-curing exposure time on orthodontic bracket shear bond 
strength. Revista Portuguesa de Estomatologia, Medicina Dentaria e Cirurgia Maxilofacial 2014; (2):78-82. 
Exclude by title. 
50 
Gomez S, Uribe S, Onetto JE, Emilson CG. SEM analysis of sealant penetration in posterior approximal enamel 
carious lesions in vivo. The journal of adhesive dentistry. 2008;10(2):151-6. Epub 2008/06/03. 
Exclude by title. 
51 
Goracci C, Gheewalla R, Kugel G, Ferrari M. Orthodontic-restorative treatment of chipped or worn incisors. American 
journal of dentistry 2001; (1):50-5. 
Exclude by title. 
52 
Goracci C, Margvelashvili M, Giovannetti A, Vichi A, Ferrari M. Shear bond strength of orthodontic brackets bonded 
with a new self-adhering flowable resin composite. Clinical oral investigations 2013; (2):609-17. 
Exclude by title. 
53 
Gungor AY, Ozcan E, Alkis H, Turkkahraman H. Effects of different bleaching methods on shear bond strengths of 
orthodontic brackets. The Angle orthodontist 2013; (4):686-90. 
Exclude by title. 
54 
Hammad SM, Enan ET. In vivo effects of two acidic soft drinks on shear bond strength of metal orthodontic brackets 
with and without resin infiltration treatment. The Angle orthodontist 2013; (4):648-52. 
Exclude by title. 
55 
Harris AMP, Joseph VP, Rossouw PE. Shear Peel Bond Strengths of Aesthetic Orthodontic Brackets. Am J Orthod 
Dentofac Orthop 1992;102(3):215-9. 
Exclude by title. 
56 
Hegarty DJ, Macfarlane TV. In vivo bracket retention comparison of a resin-modified glass ionomer cement and a 
resin-based bracket adhesive system after a year. Am J Orthod Dentofac Orthop 2002; (5):496-501. 
Exclude by title. 
57 
Ireland AJ, Soro V, Sprague SV, Harradine NW, Day C, Al-Anezi S, et al. The effects of different orthodontic 
appliances upon microbial communities. Orthodontics & craniofacial research 2014; (2):115-23. 
Exclude by title. 
58 
Isci D, Sahin Saglam AM, Alkis H, Elekdag-Turk S, Turk T. Effects of fluorosis on the shear bond strength of 
orthodontic brackets bonded with a self-etching primer. Eur J Orthod 2011; (2):161-6. 
Exclude by title. 
59 
Jia H, Zhu XY. Effect of three bonding adhesives on the orthodontic bracket loss rate in treating moderate and severe 
dental fluorosis. [Chinese]. Journal of Clinical Rehabilitative Tissue Engineering Research 2010; (16):2925-8. 
Exclude by title. 
60 
Kim YK, Lee JW, Cha KS. A comparative study on bond strength and adhesive failure pattern in bracket bonding with 
self-etching primer. Korean Journal of Orthodontics 2004; (4):325-32. 
Exclude by title. 
61 
Koch G, Hakeberg M, Petersson LG. Fluoride Uptake on Dry Versus Water-Saliva Wetted Human-Enamel Surfaces 
Invitro after Topical Application of a Varnish (Duraphat) Containing Fluoride. Swedish dental journal. 1988;12(6):221-5. 
Exclude by title. 
62 
Korbmacher HM, Huck L, Kahl-Nieke B. Fluoride-releasing adhesive and antimicrobial self-etching primer effects on 
shear bond strength of orthodontic brackets. The Angle orthodontist 2006; (5):845-50. 
Exclude by title. 
63 
Koroluk LD, Tulloch JF, Phillips C. Incisor trauma and early treatment for Class II Division 1 malocclusion. Am J 
Orthod Dentofac Orthop 2003; (2):117-25; discussion 25-6. 
Exclude by title. 
64 
Kraut J, Radin S, Trowbridge HI, Emling RC, Yankell SL. Clinical evaluations on thermal versus mechanical debonding 
of ceramic brackets. The Journal of clinical dentistry 1991; (4):92-6. 
Exclude by title. 
 65 
Kuramoto M, Jr., Matos AB, Matson E, Eduardo CP, Powers JM. Microleakage of resin-based composite restorations 
with ceramic inserts. American journal of dentistry. 2000;13(6):311-4. Epub 2002/01/05. 
Exclude by title. 
66 
Lamper T, Steinhäuser-Andresen S, Huth KC, Ilie N, Paschos E. Does a reduction of polymerization time and bonding 
steps affect the bond strength of brackets? Clinical oral investigations 2012; (2):665-71. 
Exclude by title. 
67 
Le T, Nassery K, Kahlert B, Heithersay G. A comparative diagnostic assessment of anterior tooth and bone status 
using panoramic and periapical radiography. Australian orthodontic journal 2011; (2):162-8. 
Exclude by title. 
68 
Lee BS, Hsieh TT, Lee YL, Lan WH, Hsu YJ, Wen PH, et al. Bond strengths of orthodontic bracket after acid-etched, 
Er:YAG laser-irradiated and combined treatment on enamel surface. The Angle orthodontist 2003; (5):565-70. 
Exclude by title. 
69 
Lombardo L, Bulli C, Mirabella D, Bonetti AG, Siciliani G. Comparison of adhesion forces developed by foil mesh of 
various dimensions applied in combination with composites of different viscosity. International Orthodontics 2013; 
(3):290-302. 
Exclude by title. 
70 
Lucchese A, Carinci F, Brunelli G. Use of ferric-sulphate gel for bleeding control in surgical exposure of impacted 
canines. European Journal of Inflammation 2012; (Suppl. 1):79-82.  
Exclude by title. 
71 
Magnius M, Bazargani F. Effects of oil-based and oil-free enamel prophylactic agents on bracket failure--a prospective 
randomized clinical trial. Swedish dental journal 2014; (2):87-91. 
Exclude by title. 
72 
Mahdavie NN, Manasse RJ, Viana G, Evans CA, Bedran-Russo AB. Enamel scarring by debonding burs: an SEM and 
profilometric study. Journal of clinical orthodontics : JCO 2014; (1):14-21. 
Exclude by title. 
73 
Mayne RJ, Cochrane NJ, Cai F, Woods MG, Reynolds EC. In-vitro study of the effect of casein phosphopeptide 
amorphous calcium fluoride phosphate on iatrogenic damage to enamel during orthodontic adhesive removal. Am J 
Orthod Dentofac Orthop 2011;139(6):e543-51. Epub 2011/06/07. 
Exclude by title. 
74 
Miles PG, Pontier JP, Bahiraei D, Close J. The Effect of Carbamide Peroxide Bleach on the Tensile Bond Strength of 
Ceramic Brackets - an in-Vitro Study. Am J Orthod Dentofac Orthop 1994;106(4):371-5. 
Exclude by title. 
75 
Millett Declan T, Mandall Nicky A, Mattick Rye CR, Hickman J, Glenny A-M. Adhesives for bonded molar tubes during 
fixed brace treatment. Cochrane Database of Systematic Reviews 2011; (6). 
Exclude by title. 
76 
Millett DT, Doubleday B, Alatsaris M, Love J, Wood D, Luther F, et al. Chlorhexidine-modified glass ionomer for band 
cementation? An in vitro study. Journal of orthodontics. 2005;32(1):36-42. Epub 2005/03/24. 
Exclude by title. 
77 
Mirabella D, Spena R, Scognamiglio G, Luca L, Gracco A, Siciliani G. LED vs halogen light-curing of adhesive-
precoated brackets. The Angle orthodontist 2008; (5):935-40. 
Exclude by title. 
78 
Mitchell L (1992) Decalcification during orthodontic treatment with fixed appliances—an overview. Br J Orthod 19:199–
205 
Exclude by title. 
79 
Murfitt PG, Quick AN, Swain MV, Herbison GP. A randomised clinical trial to investigate bond failure rates using a self-
etching primer. Eur J Orthod 2006; (5):444-9. 
Exclude by title. 
80 
Nandhra SS, Littlewood SJ, Houghton N, Luther F, Prabhu J, Munyombwe T, et al. Do we need primer for orthodontic 
bonding? A randomized controlled trial. Eur J Orthod 2015; (2):147-55. 
Exclude by title. 
81 
Noel L, Rebellato J, Sheats RD. The effect of argon laser irradiation on demineralization resistance of human enamel 
adjacent to orthodontic brackets: an in vitro study. Angle Orthod 2003;73(3):249-58. Epub 2003/06/28. 
Exclude by title. 
82 
Novaes TF, Matos R, Raggio DP, Imparato JC, Braga MM, Mendes FM. Influence of the discomfort reported by 
children on the performance of approximal caries detection methods. Caries research. 2010;44(5):465-71. Epub 
2010/09/24. 
Exclude by title. 
83 
Ogihara S, Wang HL. Periodontal regeneration with or without limited orthodontics for the treatment of 2- or 3-wall 
infrabony defects. Journal of periodontology 2010; (12):1734-42. 
Exclude by title. 
84 
Olivares Espinoza JA, Sáenz Pasco GJ. [Fuerzas de adhesión de un sistema adhesivo de quinta generación en 
superficies dentarias tratadas con agentes químico-mecánicos] Bond strength of a generation adhesive system to 
tooth surfaces treated with two chemical-mechanical agents. Odontol pediatr (Lima).12(1):6-13. 
Exclude by title. 
85 
Olsen ME, Bishara SE, Jakobsen JR. Evaluation of the shear bond strength of different ceramic bracket base designs. 
The Angle orthodontist 1997; (3):179-82. 
Exclude by title. 
86 
Olsson H, Davies JR, Holst KE, Schröder U, Petersson K. Dental pulp capping: effect of Emdogain Gel on 
experimentally exposed human pulps. International endodontic journal 2005; (3):186-94. 
Exclude by title. 
87 
Oskoee SS, Oskoee PA, Navimipour EJ, Shahi S. In vitro fracture resistance of endodontically-treated maxillary 
premolars. Operative dentistry 2007; (5):510-4. 
Exclude by title. 
88 
Osorio R, Toledano M, Garcia-Godoy F. Bracket bonding with 15- or 60-second etching and adhesive remaining on 
enamel after debonding. The Angle orthodontist 1999; (1):45-8. 
Exclude by title. 
89 
Ostby AW, Bishara SE, Laffoon J, Warren JJ. Influence of self-etchant application time on bracket shear bond 
strength. The Angle orthodontist 2007; (5):885-9. 
Exclude by title. 
90 
Ovrebo RC, Raadal M. Microleakage in fissures sealed with resin or glass ionomer cement. Scandinavian journal of 
dental research. 1990;98(1):66-9. Epub 1990/02/01. 
Exclude by title. 
91 
Ozta E, Ba?delen G, Kiliço?lu H, Ulukapi H, Aydin I. The effect of enamel bleaching on the shear bond strengths of 
metal and ceramic brackets. Eur J Orthod 2012; (2):232-7. 
Exclude by title. 
92 
Park SB, Kang EH, Son WS, Ko CC, Kim HI, Kwon YH. Effect of DPSS laser on the shear bond strength of 
orthodontic brackets. American journal of dentistry 2010; (4):205-7. 
Exclude by title. 
93 
Pellegrini P, Sauerwein R, Finlayson T, McLeod J, Covell DA, Maier T, et al. Plaque retention by self-ligating vs 
elastomeric orthodontic brackets: quantitative comparison of oral bacteria and detection with adenosine triphosphate-
driven bioluminescence. Am J Orthod Dentofac Orthop 2009; (4):426.e1-9; discussion -7. 
Exclude by title. 
94 
Peng Y, Wu R, Qu W, Wu W, Chen J, Fang J, et al. Effect of visual method vs plaque disclosure in enhancing oral 
hygiene in adolescents and young adults: a single-blind randomized controlled trial. Am J Orthod Dentofac Orthop 
2014; (3):280-6. 
Exclude by title. 
95 
Perdigao J, Gomes G, Gondo R, Fundingsland JW. In vitro bonding performance of all-in-one adhesives. Part I - 
Microtensile bond strengths. Journal of Adhesive Dentistry. 2006;8(6):367-73. 
Exclude by title. 
96 
Perez-Lajarin L, Cortes-Lillo O, Garcia-Ballesta C, Cozar-Hidalgo A. Marginal microleakage of two fissure sealants: a 
comparative study. Journal of dentistry for children (Chicago, Ill). 2003;70(1):24-8. Epub 2003/05/24. 
Exclude by title. 
 97 
Pratt KC, Hicks J, English JD, Bussa Jr HI, Flaitz CM, Powers JM. Fluoride-releasing orthodontic adhesives and 
topical fluoride effect on enamel caries formation: An in vitro study. American journal of dentistry. 2010;23(3):179-84. 
Exclude by title. 
98 
Pretty IA, Pender N, Edgar WM, Higham SM. The in vitro detection of early enamel de- and re-mineralization adjacent 
to bonded orthodontic cleats using quantitative light-induced fluorescence. Eur J Orthod 2003;25(3):217-23. 
Exclude by title. 
99 
Raggio DP, Sonego FG, Camargo LB, Marquezan M, Imparato JC. Efficiency of different polyacrylic acid 
concentrations on the smear layer, after ART technique, by Scanning Electron Microscopy (SEM). Eur Arch Pead Dent 
2010;11(5):232-5. Epub 2010/10/12. 
Exclude by title. 
100 
Rao B, Reddy SN, Mujeeb A, Mehta K, Saritha G. An evaluation of shear bond strength of self-etch adhesive on pre-
etched enamel: An in vitro study. Journal of Contemporary Dental Practice. 2013;14(6):1036-8. 
Exclude by title. 
101 
Rex T, Kharbanda OP, Petocz P, Darendeliler MA. Physical properties of root cementum: part 6. A comparative 
quantitative analysis of the mineral composition of human premolar cementum after the application of orthodontic 
forces. American journal of orthodontics and dentofacial orthopedics 2006; (3). 
Exclude by title. 
102 
Rios D, Honorio HM, Magalhaes AC, Delbem AC, Machado MA, Silva SM, et al. Effect of salivary stimulation on 
erosion of human and bovine enamel subjected or not to subsequent abrasion: an in situ/ex vivo study. Caries 
research. 2006;40(3):218-23. Epub 2006/05/19. 
Exclude by title. 
103 
Rosenbach G, Pedra e Cal-Neto J, Oliveira SR, Chevitarese O, Almeida MA. Effect of enamel etching on tensile bond 
strength of brackets bonded in vivo with a resin-reinforced glass lonomer cement. Angle Orthod 2007;77(1):113-6. 
Exclude by title. 
104 
Sadowsky PL, Retief DH, Cox PR, Hernandezorsini R, Rape WG, Bradley EL. Effects of Etchant Concentration and 
Duration on the Retention of Orthodontic Brackets - an Invivo Study. Am J Orthod Dentofac Orthop 1990;98(5):417-21. 
Exclude by title. 
105 
Salar DV, Garcia-Godoy F, Flaitz CM, Hicks MJ. Potential inhibition of demineralization in vitro by fluoride-releasing 
sealants. Journal of the American Dental Association (1939). 2007;138(4):502-6. Epub 2007/04/04. 
Exclude by title. 
106 
Salehi P, Zarif Najafi H, Roeinpeikar SM. Comparison of survival time between two types of orthodontic fixed retainer: 
a prospective randomized clinical trial. Progress in orthodontics 2013:25 p.]. 
Exclude by title. 
107 
Sayinsu K, Isik F, Sezen S, Aydemir B. New protective polish effects on shear bond strength of brackets. The Angle 
orthodontist 2006; (2):306-9. 
Exclude by title. 
108 
Scougall Vilchis RJ, Yamamoto S, Kitai N, Yamamoto K. Shear bond strength of orthodontic brackets bonded with 
different self-etching adhesives. Am J Orthod Dentofac Orthop 2009; (3):425-30. 
Exclude by title. 
109 
Scougall-Vilchis RJ, Zárate-Díaz C, Kusakabe S, Yamamoto K. Bond strengths of different orthodontic adhesives after 
enamel conditioning with the same self-etching primer. Australian orthodontic journal 2010; (1):84-9. 
Exclude by title. 
110 
Shammaa I, Ngan P, Kim H, Kao E, Gladwin M, Gunel E, et al. Comparison of bracket debonding force between two 
conventional resin adhesives and a resin-reinforced glass ionomer cement: an in vitro and in vivo study. The Angle 
orthodontist 1999; (5):463-9. 
Exclude by title. 
111 
Shultz PH, Brockmann-Bell SL, Eick JD, Gross KB, Chappell RP, Spencer P. Effects of air-powder polishing on the 
bond strength of orthodontic bracket adhesive systems. Journal of dental hygiene : JDH / American Dental Hygienists' 
Association 1993; (2):74-80. 
Exclude by title. 
112 
Sökücü O, Siso H, Bekta Ö, Babacan H. Shear bond strength comparison of a conventional and a self-etching 
fluoride-releasing adhesive following thermocycling. World journal of orthodontics 2010; (1):6-10. 
Exclude by title. 
113 
Sorel O, Alam R, Chagneau F, Cathelineau G. Comparison of bond strength between simple foil mesh and laser-
structured base retention brackets. Am J Orthod Dentofac Orthop 2002; (3):260-6. 
Exclude by title. 
114 
Sudjalim TR, Woods MG, Manton DJ, Reynolds EC. Prevention of demineralization around orthodontic brackets in 
vitro. Am J Orthod Dentofac Orthop 2007;131(6):705.e1-.e9. 
Exclude by title. 
115 
Summers A, Kao E, Gilmore J, Gunel E, Ngan P. Comparison of bond strength between a conventional resin adhesive 
and a resinmodified glass ionomer adhesive: An in vitro and in vivo study. Am J Orthod Dentofac Orthop 
2004;126(2):200-6. 
Exclude by title. 
116 Takla PM, Shivapuja PK. Pulpal response in electrothermal debonding. Am J Orthod Dentofac Orthop 1995; (6):623-9. Exclude by title. 
117 
Tang AT, Björkman L, Adamczak E, Andlin-Sobocki A, Ekstrand J. In vitro shear bond strength of orthodontic 
bondings without liquid resin. Acta odontologica Scandinavica 2000; (1):44-8. 
Exclude by title. 
118 
Tavares SW, Consani S, Nouer DF, Magnani MB, Nouer PR, Martins LM. Shear bond strength of new and recycled 
brackets to enamel. Brazilian dental journal 2006; (1):44-8. 
Exclude by title. 
119 
Tezel H, Ergucu Z, Onal B. Effects of topical fluoride agents on artificial enamel lesion formation in vitro. Quintessence 
international (Berlin, Germany : 1985). 2002;33(5):347-52. Epub 2002/05/17. 
Exclude by title. 
120 
Toledano M, Osorio R, Osorio E, Romeo A, Higuera B, García-Godoy F. Bond strength of orthodontic brackets using 
different light and self-curing cements. The Angle orthodontist 2003; (1):56-63. 
Exclude by title. 
121 
Trakyali G, Ozdemir FI, Arun T. Enamel colour changes at debonding and after finishing procedures using five 
different adhesives. Eur J Orthod 2009; (4):397-401. 
Exclude by title. 
122 
Trites B, Foley TF, Banting D. Bond strength comparison of 2 self-etching primers over a 3-month storage period. Am 
J Orthod Dentofac Orthop 2004; (6):709-16. 
Exclude by title. 
123 
Tuncer C, Tuncer BB, Ulusoy C. Effect of fluoride-releasing light-cured resin on shear bond strength of orthodontic 
brackets. Am J Orthod Dentofac Orthop 2009; (1):14.e1-6; discussion -5. 
Exclude by title. 
124 
Tuncer C, Ulusoy Ç. Tensile bond strength of lingual orthodontic brackets with adhesive systems. World journal of 
orthodontics 2010; (4):393-7. 
Exclude by title. 
125 
Türkkahraman H, Adanir N, Güngör AY. Bleaching and desensitizer application effects on shear bond strengths of 
orthodontic brackets. The Angle orthodontist 2007; (3):489-93. 
Exclude by title. 
126 
Türkkahraman H, Adanir N. Effects of potassium nitrate and oxalate desensitizer agents on shear bond strengths of 
orthodontic brackets. The Angle orthodontist 2007; (6):1096-100. 
Exclude by title. 
127 
Turkoz C, Tuncer BB, Ulusoy MC, Tuncer C. Bond strength of different bonding systems to the lingual surface enamel 
of mandibular incisors. Korean Journal of Orthodontics 2010; (4):260-6. 
Exclude by title. 
128 
Uysal T, Basciftci FA, S Uü, Sari Z, Buyukerkmen A. Can previously bleached teeth be bonded safely? Am J Orthod 
Dentofac Orthop 2003; (6):628-32. 
Exclude by title. 
129 Uysal T, Ustdal A, Nur M, Catalbas B. Bond strength of ceramic brackets bonded to enamel with amorphous calcium Exclude by title. 
 phosphate-containing orthodontic composite. Eur J Orthod 2010; (3):281-4. 
130 
Uysal T, Yilmaz E, Ramoglu SI. Amorphous calcium phosphate-containing orthodontic cement for band fixation: an in 
vitro study. World journal of orthodontics 2010; (2):129-34. 
Exclude by title. 
131 
Varlik SK, Ulusoy C. Effect of light-cured filled sealant on shear bond strength of metal and ceramic brackets bonded 
with a resin-modified glass ionomer cement. Am J Orthod Dentofac Orthop 2009; (2):194-8. 
Exclude by title. 
132 
Vinagre AR, Messias AL, Gomes MA, Costa AL, Ramos JC. Effect of time on shear bond strength of four orthodontic 
adhesive systems. Revista Portuguesa de Estomatologia, Medicina Dentaria e Cirurgia Maxilofacial 2014; (3):142-51. 
Exclude by title. 
133 
Yagci A, Uysal T, Akinci H, Uysal B. Effects of a new desensitizing paste containing 8% arginine and calcium 
carbonate on the shear bond strength of orthodontic brackets. Korean Journal of Orthodontics 2011; (2):121-6. 
Exclude by title. 
134 
Youngson CC, Grey NJA, Martin DM. Invitro Marginal Microleakage Associated with 5 Dentin Bonding Systems and 
Associated Composite Restorations. Journal of dentistry. 1990;18(4):203-8. 
Exclude by title. 
135 
Yu Y, Sun J, Lai W, Wu T, Koshy S, Shi Z. Interventions for managing relapse of the lower front teeth after orthodontic 
treatment. Cochrane Database of Systematic Reviews 2013; (9). 
Exclude by title. 
136 
Zaher AR, Abdalla EM, Abdel Motie MA, Rehman NA, Kassem H, Athanasiou AE. Enamel colour changes after 
debonding using various bonding systems. Journal of orthodontics 2012; (2):82-8. 
Exclude by title. 
137 
Zakavi F, Golpasand Hagh L, Sadeghian S, Freckelton V, Daraeighadikolaei A, Ghanatir E, et al. Evaluation of 
microleakage of class II dental composite resin restorations cured with LED or QTH dental curing light; Blind, Cluster 
Randomized, In vitro cross sectional study. BMC research notes 2014:416 p.]. 
Exclude by title. 
Exclusion by abstract 
138 
[No authors included] {NCT01768390} Caries-preventive Effect of a Dentifrice Containing 5,000 Ppm Fluoride in 
Orthodontic Patients. Status: Completed. 
Exclude by abstract. 
139 [No authors included] {NCT02705456} Enamel Caries in Orthodontic Patients. Status: Recruiting. Exclude by abstract. 
140 [No authors included] {NCT02359318} De-bonding Following Infiltration. Status: Recruiting. Exclude by abstract. 
141 
Adriaens ML, Dermaut LR, Verbeeck RMH. The use of 'Fluor Protector®', a fluoride varnish, as a caries prevention 
method under orthodontic molar bands. Eur J Orthod 1990;12(3):316-9. 
Exclude by abstract. 
142 
Ahrari F, Poosti M, Akbari M, Sadri K. Early versus delayed rebonding of orthodontic brackets. Progress in 
orthodontics 2012; (1):17-22.  
Exclude by abstract. 
143 
Akkaya S, Uner O, Alaçam A, De?im T. Enamel fluoride levels after orthodontic band cementation with glass ionomer 
cement. Eur J Orthod 1996; (1):81-7. 
Exclude by abstract. 
144 
Al Maaitah EF, Abu Omar AA, Al-Khateeb SN. Effect of fixed orthodontic appliances bonded with different etching 
techniques on tooth color: a prospective clinical study. Am J Orthod Dentofac Orthop 2013; (1):43-9. 
Exclude by abstract. 
145 
Al Maaitah EF, Adeyemi AA, Higham SM, Pender N, Harrison JE. Factors affecting demineralization during 
orthodontic treatment: A post-hoc analysis of RCT recruits. American Journal of Orthodontics and Dentofacial 
Orthopedics 2011; (2):181-91. 
Exclude by abstract. 
146 
Al-Khateeb S, Exterkate RA, de Josselin de Jong E, Angmar-Mansson B, ten Cate JM. Light-induced fluorescence 
studies on dehydration of incipient enamel lesions. Caries research. 2002;36(1):25-30. 
Exclude by abstract. 
147 
Al-Mulla A, Karlsson L, Kharsa S, Kjellberg H, Birkhed D. Combination of high-fluoride toothpaste and no post-
brushing water rinsing on enamel demineralization using an in-situ caries model with orthodontic bands. Acta Odont 
Scand 2010;68(6):323-8. 
Exclude by abstract. 
148 
Arnold RW, Combe EC, Warford JH. Bonding of stainless steel brackets to enamel with a new self-etching primer. Am 
J Orthod Dentofac Orthop 2002; (3):274-6. 
Exclude by abstract. 
149 
Artun J, Spadafora AT, Shapiro PA, McNeill RW, Chapko MK. Hygiene status associated with different types of 
bonded, orthodontic canine-to-canine retainers. A clinical trial. J Clin Periodontol 1987;14(2):89-94. 
Exclude by abstract. 
150 Artun J. A post-treatment evaluation of multibonded ceramic brackets in orthodontics. Eur J Orthod 1997; (2):219-28. Exclude by abstract. 
151 
Atwa A, AbuShahba RY, Mostafa M, Hashem MI. Effect of honey in preventing gingivitis and dental caries in patients 
undergoing orthodontic treatment. Saudi Dental Journal 2014; (3):108-14. 
Exclude by abstract. 
152 
Ba?aran G, Ozer T, Devecio?lu Kama J. Comparison of a recently developed nanofiller self-etching primer adhesive 
with other self-etching primers and conventional acid etching. Eur J Orthod 2009; (3):271-5. 
Exclude by abstract. 
153 
Baumgartner S, Menghini G, Imfeld T. The prevalence of approximal caries in patients after fixed orthodontic 
treatment and in untreated subjects: A retrospective, cross-sectional study on bitewing radiographs. J Orofac Orthop 
2013;74(1):64-72. 
Exclude by abstract. 
154 
Baysal A, Uysal T. Resin-modified glass ionomer cements for bonding orthodontic retainers. Eur J Orthod 2010; 
(3):254-8. 
Exclude by abstract. 
155 
Bechtold TE, Sobiegalla A, Markovic M, Berneburg M, Goz GR. In vivo effectiveness of enamel sealants around 
orthodontic brackets. J Orthofac Orthop 2013;74(6):447-57. 
Exclude by abstract. 
156 
Benham AW, Campbell PM, Buschang PH. Effectiveness of pit and fissure sealants in reducing white spot lesions 
during orthodontic treatment. A pilot study. Angle Orthod 2009;79(2):338-45. 
Exclude by abstract. 
157 
Benson PE, Pender N, Higham SM. An in situ caries model to study demineralisation during fixed orthodontics. Clin 
Orthod Res 1999;2(3):143-53. 
Exclude by abstract. 
158 
Benson Philip E, Parkin N, Dyer F, Millett Declan T, Furness S, Germain P. Fluorides for the prevention of early tooth 
decay (demineralised white lesions) during fixed brace treatment. Cochrane Database of Systematic Reviews 2013; 
(12). 
Exclude by abstract. 
159 
Bishara SE, Ajlouni R, Soliman MM, Oonsombat C, Laffoon JF, Warren J. Evaluation of a new nano-filled restorative 
material for bonding orthodontic brackets. World journal of orthodontics 2007; (1):8-12. 
Exclude by abstract. 
160 
Bishara SE, Otsby AW, Ajlouni R, Laffoon J, Warren JJ. A new premixed self-etch adhesive for bonding orthodontic 
brackets. The Angle orthodontist 2008; (6):1101-4. 
Exclude by abstract. 
161 
Bock NC, von Bremen J, Kraft M, Ruf S. Plaque control effectiveness and handling of interdental brushes during 
multibracket treatment-a randomized clinical trial. Eur J Orthod 2010;32(4):408-13. 
Exclude by abstract. 
162 
Buck T, Pellegrini P, Sauerwein R, Leo MC, Covell DA, Jr., Maier T, et al. Elastomeric-ligated vs self-ligating 
appliances: a pilot study examining microbial colonization and white spot lesion formation after 1 year of orthodontic 
Exclude by abstract. 
 treatment. Orthodontics : the art and practice of dentofacial enhancement. 2011;12(2):108-21. Epub 2011/09/22. 
163 
Burgess AM, Sherriff M, Ireland AJ. Self-etching primers: is prophylactic pumicing necessary? A randomized clinical 
trial. The Angle orthodontist 2006; (1):114-8. 
Exclude by abstract. 
164 
Büyükyilmaz T, Tangugsorn V, Ogaard B, Arends J, Ruben J, Rølla G. The effect of titanium tetrafluoride (TiF4) 
application around orthodontic brackets. Am J Orthod Dentofac Orthop 1994; (3):293-6. 
Exclude by abstract. 
165 
Cacciafesta V, Bosch C, Melsen B. Clinical comparison between a resin-reinforced self-cured glass ionomer cement 
and a composite resin for direct bonding of orthodontic brackets. Part 2: Bonding on dry enamel and on enamel 
soaked with saliva. Clinical orthodontics and research 1999; (4):186-93. 
Exclude by abstract. 
166 
Carstensen W. Clinical effects of reduction of acid concentration on direct bonding of brackets. The Angle orthodontist 
1993; (3):221-4. 
Exclude by abstract. 
167 
Casals E, Boukpessi T, McQueen CM, Eversole SL, Faller RV. Anticaries potential of commercial dentifrices as 
determined by fluoridation and remineralization efficiency. Journal of Contemporary Dental Practice. 2007;8(7):001-10. 
Exclude by abstract. 
168 
Chimello DT, Serra MC, Rodrigues-Junior AL, Pecora JD, Corona SA. Influence of Er:YAG laser on microhardness of 
enamel adjacent to restorations submitted to cariogenic challenge in situ. Photomedicine and laser surgery. 
2008;26(4):379-85. Epub 2008/07/31. 
Exclude by abstract. 
169 
Chung CK, Millett DT, Creanor SL, Gilmour WH, Foye RH. Fluoride release and cariostatic ability of a compomer and 
a resin-modified glass ionomer cement used for orthodontic bonding. J Dent 1998;26(5-6):533-8. 
Exclude by abstract. 
170 
Coelho-De-Souza FH, Camargo JC, Beskow T, Balestrin MD, Klein-Júnior CA, Demarco FF. A randomized double-
blind clinical trial of posterior composite restorations with or without bevel: 1-year follow-up. J appl oral sci.20(2):174-9. 
Exclude by abstract. 
171 
Dalessandri D, Dalessandri M, Bonetti S, Visconti L, Paganelli C. Effectiveness of an indirect bonding technique in 
reducing plaque accumulation around braces. Angle Orthod 2012;82(2):313-8. Epub 2011/08/19. 
Exclude by abstract. 
172 
de Moura MS, de Melo Simplicio AH, Cury JA. In-vivo effects of fluoridated antiplaque dentifrice and bonding material 
on enamel demineralization adjacent to orthodontic appliances. Am J Orthod Dentofac Orthop 2006;130(3):357-63. 
Epub 2006/09/19. 
Exclude by abstract. 
173 
Derks A, Frencken J, Bronkhorst E, Kuijpers-Jagtman AM, Katsaros C. Effect of chlorhexidine varnish application on 
mutans streptococci counts in orthodontic patients. Am J Orthod Dentofac Orthop 2008;133(3):435-9. Epub 
2008/03/12. 
Exclude by abstract. 
174 
Doherty UB, Benson PE, Higham SM. Fluoride-releasing elastomeric ligatures assessed with the in situ caries model. 
Eur J Orthod 2002;24(4):371-8. Epub 2002/08/30. 
Exclude by abstract. 
175 
Dong YN, Chen M, Ren XM. Effect of fluor protector on preventing enamel demineralization. Journal of Clinical 
Rehabilitative Tissue Engineering Research 2009; (25):4997-5000. 
Exclude by abstract. 
176 
Eppright M, Shroff B, Best AM, Barcoma E, Lindauer SJ. Influence of active reminders on oral hygiene compliance in 
orthodontic patients. Angle Orthod 2014;84(2):208-13. Epub 2013/09/14. 
Exclude by abstract. 
177 
Faria-Júnior É M, Guiraldo RD, Berger SB, Correr AB, Correr-Sobrinho L, Contreras EF, et al. In-vivo evaluation of the 
surface roughness and morphology of enamel after bracket removal and polishing by different techniques. Am J 
Orthod Dentofac Orthop 2015; (3):324-9.  
Exclude by abstract. 
178 
Fekrazad R, Ebrahimpour L. Evaluation of acquired acid resistance of enamel surrounding orthodontic brackets 
irradiated by laser and fluoride application. Lasers in medical science 2013; (6):1793-8. 
Exclude by abstract. 
179 
Foek DL, Ozcan M, Krebs E, Sandham A. Adhesive properties of bonded orthodontic retainers to enamel: stainless 
steel wire vs fiber-reinforced composites. The journal of adhesive dentistry. 2009;11(5):381-90. Epub 2009/10/21. 
Exclude by abstract. 
180 
Fornell AC, Skold-Larsson K, Hallgren A, Bergstrand F, Twetman S. Effect of a hydrophobic tooth coating on gingival 
health, mutans streptococci, and enamel demineralization in adolescents with fixed orthodontic appliances. Acta 
odontologica Scandinavica. 2002;60(1):37-41. Epub 2002/03/21. 
Exclude by abstract. 
181 
Garcia-Godoy F, Hubbard GW, Storey AT. Effect of a fluoridated etching gel on enamel morphology and shear bond 
strength of orthodontic brackets. Am J Orthod Dentofac Orthop 1991; (2):163-70. 
Exclude by abstract. 
182 
Ghiz MA, Ngan P, Kao E, Martin C, Gunel E. Effects of sealant and self-etching primer on enamel decalcification. Part 
II: an in-vivo study. Am J Orthod Dentofac Orthop 2009;135(2):206-13. 
Exclude by abstract. 
183 
Gillgrass TJ, Benington PC, Millett DT, Newell J, Gilmour WH. Modified composite or conventional glass ionomer for 
band cementation? A comparative clinical trial. Am J Orthod Dentofac Orthop 2001;120(1):49-53. Epub 2001/07/17. 
Exclude by abstract. 
184 
Gorelick L, Geiger AM, Gwinnett AJ. Incidence of white spot formation after bonding and banding. Am J Orthod 
1982;81(2):93-8. 
Exclude by abstract. 
185 
Gorton J, Featherstone JD. In vivo inhibition of demineralization around orthodontic brackets. Am J Orthod Dentofac 
Orthop 2003;123(1):10-4. Epub 2003/01/18. 
Exclude by abstract. 
186 
Gorton J, Featherstone JDB. In vivo inhibition of deraineralization around orthodontic brackets. Am J Orthod Dentofac 
Orthop 2003;123(1):10-4. 
Exclude by abstract. 
187 
Gray A, Ferguson MM. The use of low-tack chewing gum for individuals wearing orthodontic appliances. Australian 
dental journal. 1996;41(6):373-6. Epub 1996/12/01. 
Exclude by abstract. 
188 
Heintze SD, Jost-Brinkmann PG, Loundos J. Effectiveness of three different types of electric toothbrushes compared 
with a manual technique in orthodontic patients. Am J Orthod Dentofac Orthop 1996; (6):630-8. 
Exclude by abstract. 
189 
Hess E, Campbell PM, Honeyman AL, Buschang PH. Determinants of enamel decalcification during simulated 
orthodontic treatment. Angle Orthod 2011;81(5):836-42. Epub 2011/05/07. 
Exclude by abstract. 
190 
Hildebrand NK, Raboud DW, Heo G, Nelson AE, Major PW. Argon laser vs conventional visible light-cured orthodontic 
bracket bonding: an in-vivo and in-vitro study. Am J Orthod Dentofac Orthop 2007; (4):530-6. 
Exclude by abstract. 
191 
House K, Ireland AJ, Sherriff M. An investigation into the use of a single component self-etching primer adhesive 
system for orthodontic bonding: a randomized controlled clinical trial. Journal of orthodontics 2006; (1):38-44; 
discussion 28.  
Exclude by abstract. 
192 
Hu H, Li C, Li F, Chen J, Sun J, Zou S, et al. Enamel etching for bonding fixed orthodontic braces. Cochrane Database 
of Systematic Reviews 2013; (11). 
Exclude by abstract. 
193 
Jiang H, Hua F, Yao L, Tai B, Du M. Effect of 1.23% acidulated phosphate fluoride foam on white spot lesions in 
orthodontic patients: a randomized trial. Pediatric dentistry. 2013;35(3):275-8. Epub 2013/06/13. 
Exclude by abstract. 
 194 
Knoesel M, Klang E, Helms H-J, Wiechmann D. Lingual orthodontic treatment duration: performance of two different 
completely customized multi-bracket appliances (Incognito and WIN) in groups with different treatment complexities. 
Head & Face Medicine. 2014;10. 
Exclude by abstract. 
195 
Knosel M, Bojes M, Jung K, Ziebolz D. Increased susceptibility for white spot lesions by surplus orthodontic etching 
exceeding bracket base area. Am J Orthod Dentofac Orthop 2012;141(5):574-82. Epub 2012/05/05. 
Exclude by abstract. 
196 
Knösel M, Forslund L, Jung K, Ziebolz D. Efficacy of different strategies in protecting enamel against demineralization 
during fixed orthodontic treatment. J Orthofac Orthop 2012; (3):194-203. 
Exclude by abstract. 
197 
Korbmacher H, Huck L, Adam T, Kahl-Nieke B. Evaluation of an antimicrobial and fluoride-releasing self-etching 
primer on the shear bond strength of orthodontic brackets. Eur J Orthod 2006;28(5):457-61. Epub 2006/06/10. 
Exclude by abstract. 
198 
Krell KV, Courey JM, Bishara SE. Orthodontic bracket removal using conventional and ultrasonic debonding 
techniques, enamel loss, and time requirements. Am J Orthod Dentofac Orthop 1993; (3):258-66. 
Exclude by abstract. 
199 
Kustarci A, Sokucu O. Effect of chlorhexidine gluconate, Clearfil Protect Bond, and KTP laser on microleakage under 
metal orthodontic brackets with thermocycling. Photomedicine and laser surgery 2010:S57-62. 
Exclude by abstract. 
200 
Mandall Nicky A, Hickman J, Macfarlane Tatiana V, Mattick Rye CR, Millett Declan T, Worthington Helen V. Adhesives 
for fixed orthodontic brackets. Cochrane Database of Systematic Reviews 2003; (2). 
Exclude by abstract. 
201 
Marcushamer M, Garcia-Godoy F, Chan DC. Caries protection after orthodontic band cementation with glass ionomer. 
ASDC journal of dentistry for children. 1993;60(4-5):300-3. 
Exclude by abstract. 
202 
Marini I, Pelliccioni GA, Vecchiet F, Alessandri Bonetti G, Checchi L. A retentive system for intra-oral fluoride release 
during orthodontic treatment. Eur J Orthod 1999;21(6):695-701. Epub 2000/02/09. 
Exclude by abstract. 
203 
Mathews MS, Amaechi BT, Ramalingam K, Ccahuana-Vasquez RA, Chedjieu IP, Mackey AC, et al. In situ 
remineralisation of eroded enamel lesions by NaF rinses. Archives of oral biology 2012; (5):525-30. 
Exclude by abstract. 
204 
Mattick CR, Mitchell L, Chadwick SM, Wright J. Fluoride-releasing elastomeric modules reduce decalcification: a 
randomized controlled trial. Journal of orthodontics 2001; (3):217-9. 
Exclude by abstract. 
205 
Mehta A, Paramshivam G, Chugh VK, Singh S, Halkai S, Kumar S. Effect of light-curable fluoride varnish on enamel 
demineralization adjacent to orthodontic brackets: an in-vivo study. American Journal of Orthodontics and Dentofacial 
Orthopedics 2015; (5):814-20. 
Exclude by abstract. 
206 
Mensinkai PK, Ccahuana-Vasquez RA, Chedjieu I, Amaechi BT, Mackey AC, Walker TJ, et al. In situ remineralization 
of white-spot enamel lesions by 500 and 1,100 ppm F dentifrices. Clin Oral Invest 2012;16(4):1007-14. Epub 
2011/07/14. 
Exclude by abstract. 
207 
Millett DT, McCluskey LA, McAuley F, Creanor SL, Newell J, Love J. A comparative clinical trial of a compomer and a 
resin adhesive for orthodontic bonding. Angle Orthod 2000;70(3):233-40. Epub 2000/08/05. 
Exclude by abstract. 
208 
Millett DT, Nunn JH, Welbury RR, Gordon PH. Decalcification in relation to brackets bonded with glass ionomer 
cement or a resin adhesive. The Angle orthodontist 1999; (1):65-70. 
Exclude by abstract. 
209 
Miresmaeili A, Farhadian N, Rezaei-soufi L, Saharkhizan M, Veisi M. Effect of carbon dioxide laser irradiation on 
enamel surface microhardness around orthodontic brackets. Am J Orthod Dentofac Orthop 2014;146(2):161-5. Epub 
2014/08/03. 
Exclude by abstract. 
210 
Miura KK, Ito IY, Enoki C, Elias AM, Matsumoto MA. Anticariogenic effect of fluoride-releasing elastomers in 
orthodontic patients. Brazilian oral research. 2007;21(3):228-33. Epub 2007/08/22. 
Exclude by abstract. 
211 
Murray JJ, Vernazza CR, Holmes RD. Forty years of national surveys: An overview of children's dental health from 
1973-2013. Br Dent J 2015;219(6):281-5. 
Exclude by abstract. 
212 
Nantanee R, Santiwong B, Trairatvorakul C, Hamba H, Tagami J. Silver diamine fluoride and glass ionomer 
differentially remineralize early caries lesions, in situ. Clin Oral Invest 2015. 
Exclude by abstract. 
213 
Nazir M, Walsh T, Mandall NA, Matthew S, Fox D. Banding versus bonding of first permanent molars: a multi-centre 
randomized controlled trial. Journal of orthodontics. 2011;38(2):81-9. Epub 2011/06/17. 
Exclude by abstract. 
214 
Norevall LI, Marcusson A, Persson M. A clinical evaluation of a glass ionomer cement as an orthodontic bonding 
adhesive compared with an acrylic resin. Eur J Orthod 1996; (4):373-84. 
Exclude by abstract. 
215 
Norris DS, McInnes-Ledoux P, Schwaninger B, Weinberg R. Retention of orthodontic bands with new fluoride-
releasing cements. American journal of orthodontics 1986; (3):206-11. 
Exclude by abstract. 
216 
Ogaard B, Alm AA, Larsson E, Adolfsson U. A prospective, randomized clinical study on the effects of an amine 
fluoride/stannous fluoride toothpaste/mouthrinse on plaque, gingivitis and initial caries lesion development in 
orthodontic patients. Eur J Orthod 2006;28(1):8-12. Epub 2005/10/19. 
Exclude by abstract. 
217 
Ogaard B, Larsson E, Glans R, Henriksson T, Birkhed D. Antimicrobial effect of a chlorhexidine-thymol varnish 
(Cervitec) in orthodontic patients. A prospective, randomized clinical trial. J Orthofac Orthop 1997;58(4):206-13. Epub 
1997/01/01. 
Exclude by abstract. 
218 
Ogaard B, Larsson E, Henriksson T, Birkhed D, Bishara SE. Effects of combined application of antimicrobial and 
fluoride varnishes in orthodontic patients. Am J Orthod Dentofac Orthop 2001;120(1):28-35. Epub 2001/07/17. 
Exclude by abstract. 
219 
Oh EJ, Park SS, Jang MJ, Jeon YM, Kim JG. Experimental brush wear pattern and cariostatic effect of Biscover. 
Korean J Orthod 2008;38(3):214-22. 
Exclude by abstract. 
220 
Olympio KP, Bardal PA, JR MB, Buzalaf MA. Effectiveness of a chlorhexidine dentifrice in orthodontic patients: a 
randomized-controlled trial. Journal of clinical periodontology 2006; (6):421-6. 
Exclude by abstract. 
221 
O'Reilly MM, Featherstone JD. Demineralization and remineralization around orthodontic appliances: an in vivo study. 
Am J Orthod Dentofac Orthop 1987;92(1):33-40. Epub 1987/07/01. 
Exclude by abstract. 
222 
O'Reilly MT, De Jesus Vinas J, Hatch JP. Effectiveness of a sealant compared with no sealant in preventing enamel 
demineralization in patients with fixed orthodontic appliances: a prospective clinical trial. Am J Orthod Dentofac Orthop 
2013;143(6):837-44. Epub 2013/06/04. 
Exclude by abstract. 
223 
Ozer M, Arici S. Sandblasted metal brackets bonded with resin-modified glass ionomer cement in vivo. The Angle 
orthodontist 2005; (3):406-9. 
Exclude by abstract. 
224 
Park CH, Hwang HS, Lee KH, Hong SJ. A comparative study of electric and manual toothbrushes on oral hygiene 
status in fixed orthodontic patients. Korean Journal of Orthodontics 2004; (4):363-70. 
Exclude by abstract. 
225 Paschos E, Kurochkina N, Huth KC, Hansson CS, Rudzki-Janson I. Failure rate of brackets bonded with antimicrobial Exclude by abstract. 
 and fluoride-releasing, self-etching primer and the effect on prevention of enamel demineralization. Am J Orthod 
Dentofac Orthop 2009; (5):613-20. 
226 
Pascotto RC, Navarro MF, Capelozza Filho L, Cury JA. In vivo effect of a resin-modified glass ionomer cement on 
enamel demineralization around orthodontic brackets. Am J Orthod Dentofac Orthop 2004;125(1):36-41. Epub 
2004/01/14. 
Exclude by abstract. 
227 
Passalini P, da Silva Fidalgo TK, Caldeira EM, Gleiser R, da Cunha Goncalves Nojima M, Maia LC. Mechanical 
properties of one and twostep fluoridated orthodontic resins submitted to different pH cycling regimes. Brazilian oral 
research. 2010;24(2):197-203. 
Exclude by abstract. 
228 
Perrini F, Lombardo L, Arreghini A, Medori S, Siciliani G. Caries prevention during orthodontic treatment: In-vivo 
assessment of high-fluoride varnish to prevent white spot lesions. Am J Orthod Dentofac Orthop 2016;149(2):238-43. 
Exclude by abstract. 
229 
Polat O, Gokcelik A, Arman A, Arhun N. A comparison of white spot lesion formation between a self-ligating bracket 
and a conventional preadjusted straight wire bracket. World journal of orthodontics. 2008;9(2):e46-50. Epub 
2009/07/31. 
Exclude by abstract. 
230 
Poureslami HR, Khazaeli P, Sajadi F, Hasanzadeh H. Comparison of fluoride uptake into enamel from sodium fluoride 
gel 0.05% produced in Iran and stannous fluoride 0.4% gel. [Persian]. Journal of Kerman University of Medical 
Sciences 2012; (2):140-8. 
Exclude by abstract. 
231 
Prabhakar AR, Mahantesh T, Ahuja V. Comparison of retention and demineralization inhibition potential of adhesive 
banding cements in primary teeth. Journal of dentistry for children (Chicago, Ill). 2010;77(2):66-71. Epub 2010/09/08. 
Exclude by abstract. 
232 
Rechmann P, Fried D, Le CQ, Nelson G, Rapozo-Hilo M, Rechmann BM, et al. Caries inhibition in vital teeth using 
9.6-mum CO2-laser irradiation. Journal of biomedical optics. 2011;16(7):071405. Epub 2011/08/03. 
Exclude by abstract. 
233 
Reichl P, Farman AG, Scarfe WC, Goldsmith LJ. RVG-S, VIXA, and Ektaspeed film in detection of proximal enamel 
defects under orthodontic bands. Angle Orthod 1996;66(1):65-72. Epub 1996/01/01. 
Exclude by abstract. 
234 
Restrepo M, Bussaneli DG, Jeremias F, Cordeiro RCL, Magalhaes AC, Palomari Spolidorio DM, et al. Control of white 
spot lesion adjacent to orthodontic bracket with use of fluoride varnish or chlorhexidine gel. Scientific World Journal 
2015. 
Exclude by abstract. 
235 
Ribeiro JLdO, Bezerra RB, Campos EdJ, Freitas AAd. [Avaliação da resistência adesiva e do padrão de descolagem 
de diferentes sistemas de colagem de braquetes associados à clorexidina] Evaluation of the bond strength and 
debonding pattern of different bracket bonding systems associated with chlorhexidine. Rev dent press ortodon 
ortopedi facial.13(4):117-26. 
Exclude by abstract. 
236 
Richter AE, Arruda AO, Peters MC, Sohn W. Incidence of caries lesions among patients treated with comprehensive 
orthodontics. Am J Orthod Dentofac Orthop 2011;139(5):657-64. 
Exclude by abstract. 
237 
Robertson MA, Kau CH, English JD, Lee RP, Powers J, Nguyen JT. MI Paste Plus to prevent demineralization in 
orthodontic patients: a prospective randomized controlled trial. Am J Orthod Dentofac Orthop 2011;140(5):660-8. Epub 
2011/11/05. 
Exclude by abstract. 
238 
Rodrigues L, Parisotto T, Steiner-Oliveira C, Azevedo L, Tabchoury C, Nobre-Dos-Santos M. Effect of CO2 laser and 
fluoride dentifrice on demineralization around orthodontic brackets-an in situ study. Lasers in surgery and medicine 
2014:57 p.]. 
Exclude by abstract. 
239 
Sayinsu K, Isik F, Sezen S, Aydemir B. Effect of blood and saliva contamination on bond strength of brackets bonded 
with a protective liquid polish and a light-cured adhesive. Am J Orthod Dentofac Orthop 2007;131(3):391-4. Epub 
2007/03/10. 
Exclude by abstract. 
240 
Schlueter N, Klimek J, Ganss C. Effect of a chitosan additive to a Sn2+-containing toothpaste on its anti-erosive/anti-
abrasive efficacy-a controlled randomised in situ trial. Clin Oral Invest 2014;18(1):107-15. 
Exclude by abstract. 
241 
Schnebel B, Mateer S, Maganzini AL, Freeman K. Clinical acceptability of two self-etch adhesive resins for the 
bonding of orthodontic brackets to enamel. Journal of orthodontics 2012; (4):256-61. 
Exclude by abstract. 
242 
Shan LH, Cui ZQ, Shen QH, Gao Q, Qiu ZX. Application of light-cure resin-modified glass ionomer cement in 
orthodontic practice. Journal of Clinical Rehabilitative Tissue Engineering Research 2008; (6):1149-52. 
Exclude by abstract. 
243 
Sköld-Larsson K, Sollenius O, Karlsson L, Petersson LG, Twetman S. Effect of fluoridated milk on enamel 
demineralization adjacent to fixed orthodontic appliances. Acta odontologica Scandinavica 2013; (3-4):464-8. 
Exclude by abstract. 
244 
Sonesson M, Twetman S, Bondemark L. Effectiveness of high-fluoride toothpaste on enamel demineralization during 
orthodontic treatment - a multicentre randomized controlled trial [abstract]. Journal of orthodontics 2014; (2):158 p.]. 
Exclude by abstract. 
245 
Sonesson M, Twetman S, Bondemark L. Effectiveness of high-fluoride toothpaste on enamel demineralization during 
orthodontic treatment-a multicenter randomized controlled trial. Eur J Orthod 2014; (6):678-82. 
Exclude by abstract. 
246 
Songsiripradubboon S, Hamba H, Trairatvorakul C, Tagami J. Sodium fluoride mouthrinse used twice daily increased 
incipient caries lesion remineralization in an in situ model. Journal of dentistry. 2014;42(3):271-8. Epub 2014/01/08. 
Exclude by abstract. 
247 
Stecksen-Blicks C, Renfors G, Oscarson ND, Bergstrand F, Twetman S. Caries-preventive effectiveness of a fluoride 
varnish: a randomized controlled trial in adolescents with fixed orthodontic appliances. Caries research. 
2007;41(6):455-9. Epub 2007/09/11. 
Exclude by abstract. 
248 
Talic NF. Effect of fluoridated paste on the failure rate of precoated brackets bonded with self-etching primer: a 
prospective split-mouth study. Am J Orthod Dentofac Orthop 2011; (4):527-30. 
Exclude by abstract. 
249 Kamp A. Removal of white spot lesions by controlled acidpumice abrasion. J Clin Orthod 1989;13:690-3. Exclude by abstract. 
250 
Tanna N, Kao E, Gladwin M, Ngan PW. Effects of sealant and self-etching primer on enamel decalcification. Part I: an 
in-vitro study. Am J Orthod Dentofac Orthop 2009; (2):199-205. 
Exclude by abstract. 
251 
Trairatvorakul C, Techalertpaisarn P, Siwawut S, Ingprapankorn A. Effect of glass ionomer cement and fluoride 
varnish on the remineralization of artificial proximal caries in situ. The Journal of clinical pediatric dentistry. 
2009;34(2):131-4. Epub 2010/03/20. 
Exclude by abstract. 
252 
Trimpeneers LM, Dermaut LR. A clinical evaluation of the effectiveness of a fluoride-releasing visible light-activated 
bonding system to reduce demineralization around orthodontic brackets. Am J Orthod Dentofac Orthop 
1996;110(2):218-22. Epub 1996/08/01. 
Exclude by abstract. 
253 
Tufekci E, Pennella DR, Mitchell JC, Best AM, Lindauer SJ. Efficacy of a fluoride-releasing orthodontic primer in 
reducing demineralization around brackets: an in-vivo study. Am J Orthod Dentofac Orthop 2014;146(2):207-14. Epub 
Exclude by abstract. 
 2014/08/03. 
254 
Twetman S, Hallgren A, Petersson LG. Effect of an antibacterial varnish on mutans streptococci in plaque from 
enamel adjacent to orthodontic appliances. Caries research. 1995;29(3):188-91. Epub 1995/01/01. 
Exclude by abstract. 
255 
Ullsfoss BN, Ogaard B, Arends J, Ruben J, Rolla G, Afseth J. Effect of a combined chlorhexidine and NaF mouthrinse: 
an in vivo human caries model study. Scandinavian journal of dental research. 1994;102(2):109-12. Epub 1994/04/01. 
Exclude by abstract. 
256 
Uysal T, Akkurt MD, Amasyali M, Ozcan S, Yagci A, Basak F, et al. Does a chitosan-containing dentifrice prevent 
demineralization around orthodontic brackets? Angle Orthod 2011;81(2):319-25. 
Exclude by abstract. 
257 
Uysal T, Amasyali M, Koyuturk AE, Ozcan S. Effects of different topical agents on enamel demineralization around 
orthodontic brackets: an in vivo and in vitro study. Australian dental journal. 2010;55(3):268-74. Epub 2010/10/05. 
Exclude by abstract. 
258 
Paris S, Meyer-Lueckel H. Masking of labial enamel white spot lesions by resin infiltration—a clinical report. 
Quintessence Int 2009;40:713-8. 
Exclude by abstract. 
259 
Welbury RR, Carter NE (1993). The hydrochloric acid-pumice microabrasion technique in the treatment of post-
orthodontic decalcification. Br J Orthod 20:181-185. 
Exclude by abstract. 
260 
Welbury RR, Shaw L. A simple technique for removal of mottling, opacities and pigmentation from enamel. Dent 
Update 1990;17:161-3. 
Exclude by abstract. 
261 
Willmot DR. A randomized trial of the treatment of postorthodontic enamel white spot lesions with mouth rinses. 
(BSPD Abstract). International journal of paediatric dentistry / the British Paedodontic Society [and] the International 
Association of Dentistry for Children 2002; (5). 
Exclude by abstract. 
262 
Uysal T, Amasyali M, Ozcan S, Koyuturk AE, Sagdic D. Effect of antibacterial monomer-containing adhesive on 
enamel demineralization around orthodontic brackets: an in-vivo study. Am J Orthod Dentofac Orthop 
2011;139(5):650-6. Epub 2011/05/04. 
Exclude by abstract. 
263 
Uysal T, Ramoglu SI, Ertas H, Ulker M. Microleakage of orthodontic band cement at the cement-enamel and cement-
band interfaces. Am J Orthod Dentofac Orthop 2010; (4):534-9. 
Exclude by abstract. 
264 
van der Linden RP, Dermaut LR. White spot formation under orthodontic bands cemented with glass ionomer with or 
without Fluor Protector. Eur J Orthod 1998;20(3):219-24. Epub 1998/08/12. 
Exclude by abstract. 
265 
van der Veen MH, Attin R, Schwestka-Polly R, Wiechmann D. Caries outcomes after orthodontic treatment with fixed 
appliances: do lingual brackets make a difference? Eur J Oral Sci 2010;118(3):298-303. Epub 2010/06/25. 
Exclude by abstract. 
266 
VanMiller EJ, Donly KJ. Enamel demineralization inhibition by cements at orthodontic band margins. American journal 
of dentistry 2003; (5):356-8. 
Exclude by abstract. 
267 
Vivaldi-Rodrigues G, Demito CF, Bowman SJ, Ramos AL. The effectiveness of a fluoride varnish in preventing the 
development of white spot lesions. World journal of orthodontics. 2006;7(2):138-44. Epub 2006/06/20. 
Exclude by abstract. 
268 
Wagner L, Szepietowska M. Fluoride penetration from three orthodontic adhesives: An experimental study. Korean J 
Orthod 2013;43(1):29-34. 
Exclude by abstract. 
269 
Wenderoth CJ, Weinstein M, Borislow AJ. Effectiveness of a fluoride-releasing sealant in reducing decalcification 
during orthodontic treatment. Am J Orthod Dentofac Orthop 1999;116(6):629-34. Epub 1999/12/10. 
Exclude by abstract. 
270 
Wilson RM, Donly KJ. Demineralization around orthodontic brackets bonded with resin-modified glass ionomer cement 
and fluoride-releasing resin composite. Pediatric dentistry. 2001;23(3):255-9. Epub 2001/07/13. 
Exclude by abstract. 
271 
Yagci A, Uysal T, Ulker M, Ramoglu SI. Microleakage under orthodontic brackets bonded with the custom base 
indirect bonding technique. Eur J Orthod 2010; (3):259-63. 
Exclude by abstract. 
272 
Yang QL, Chen SJ, Wan Y, Geng C, Rong GY. Occlusion of dentinal tubules using tricalcium silicate. Chinese Journal 
of Tissue Engineering Research 2013; (38):6740-6. 
Exclude by abstract. 
273 
Yang TY, Deng RJ. Bonding of brackets using resin reinforced glass ionomer combined with a newly self-etching 
adhesive agent. [Chinese]. Journal of Clinical Rehabilitative Tissue Engineering Research 2009; (34):6729-32. 
Exclude by abstract. 
274 
Yap J, Walsh LJ, Naser-Ud Din S, Ngo H, Manton DJ. Evaluation of a novel approach in the prevention of white spot 
lesions around orthodontic brackets. Australian dental journal. 2014;59(1):70-80. 
Exclude by abstract. 
275 
Yun MS, Lee SM, Yang BH. Modified laser etching technique of enamel for bracket bonding. Korean Journal of 
Orthodontics 2010; (2):87-94. 
Exclude by abstract. 
276 
Zhu XH, Ma WZ, Lin JH. Effects of different permeating time of penetrating resin on permeating depth of early artificial 
enamel caries. [Chinese]. Journal of Shanghai Jiaotong University (Medical Science) 2015; (2):189-92. 
Exclude by abstract. 
277 
Zimmer BW, Rottwinkel Y. Assessing patient-specific decalcification risk in fixed orthodontic treatment and its impact 
on prophylactic procedures. Am J Orthod Dentofac Orthop 2004;126(3):318-24. Epub 2004/09/10. 
Exclude by abstract. 
Exclusion by fulltext 
278 
Sonesson M, Bergstrand F, Gizani S, Twetman S. Management of post-orthodontic white spot lesions: an updated 
systematic review. Eur J Orthod. 2016 [Epub ahead of print] 
Exclude by fulltext; 
systematic review. 
279 
Filho CF, Lima KC. [Eficacia del uso tópico de fluoruros y del cepillado en el control de caries producidas ôin vivoö: 
revisión sistemática] Efectiveness of the use of topical fluoride and of toothbrushing in the control of caries produced 
ôin vivoö: systematic review. Av Odontoestomatol.24(4):277-88. 
Exclude by fulltext; 
systematic review. 
280 
Chen H, Liu X, Dai J, Jiang Z, Guo T, Ding Y. Effect of remineralizing agents on white spot lesions after orthodontic 
treatment: A systematic review. Am J Orthod Dentofac Orthop 2013;143(3):376-82.e3. 
Exclude by fulltext; 
systematic review. 
281 
Bergstrand F, Twetman S. A review on prevention and treatment of post-orthodontic white spot lesions - evidence-
based methods and emerging technologies. Open Dent J 2011; (5):158-62. 
Exclude by fulltext; 
systematic review. 
282 Bishara SE (2008) White spot lesions: formation, prevention, and treatment. Semin Orthod 14:174–182 
Exclude by fulltext; no 
clinical study. 
283 
Bergstrand F, Twetman S (2003) Evidence for the efficacy of various methods of treating white-spot lesions after 
debonding of fixed orthodontic appliances. J Clin Orthod 37:19–21 
Exclude by fulltext; no 
clinical study. 
284 
Neuhaus KW, Graf M, Lussi A, Katsaros C. Late infiltration of postorthodontic white spot lesions. J Orofac Orthop 
2010;71:442-7. 
Exclude by fulltext; no 
clinical study. 
285 Willmot D. White spot lesions after orthodontic treatment. Semin Orthod 2008; 14: 209–219. 
Exclude by fulltext; no 
clinical study. 
286 Kaaij NC, Veen MH, Kaaij MA, Cate JM. A prospective, randomized placebo-controlled clinical trial on the effects of a Exclude by fulltext; WSLs 
 fluoride rinse on white spot lesion development and bleeding in orthodontic patients. European journal of oral sciences 
2015; (3):186-93. 
not assessed after ortho-
Tx. 
287 
O'Reilly MM, Featherstone JD. Demineralization and remineralization around orthodontic appliances: an in vivo study. 
Am J Orthod Dentofacial Orthop. 1987 Jul;92(1):33-40. 
Exclude by fulltext; WSLs 
not assessed after ortho-
Tx. 
288 
Aykut-Yetkiner A, Kara N, Ateş M, Ersin N, Ertuğrul F. Does casein phosphopeptid amorphous calcium phosphate 
provide remineralization on white spot lesions and inhibition of Streptococcus mutans? J Clin Pediatr Dent. 2014 
Summer;38(4):302-6. 
Exclude by fulltext; WSLs 
not assessed after ortho-
Tx. 
289 
Øgaard B, R€olla G, Arends J, ten Cate JM. Orthodontic appliances and enamel demineralization. Part 2. Prevention 
and treatment of lesions. Am J Orthod Dentofacial Orthop 1988;94:123-8. 
Exclude by fulltext; WSLs 
not assessed after ortho-
Tx. 
290 
Uysal T, Amasyali M, Ozcan S, Koyuturk AE, Akyol M, Sagdic D. In vivo effects of amorphous calcium phosphate-
containing orthodontic composite on enamel demineralization around orthodontic brackets. Aust Dent J. 2010;55:285–
91. 
Exclude by fulltext; WSLs 
not assessed after ortho-
Tx. 
291 
Al-Khateeb S, Forsberg CM, De Josselin De Jong E, Angmar-Ma°nsson B. A longitudinal laser fluorescence study of 
white spot lesions in orthodontic patients. Am J Orthod Dentofac Orthop 1998; 113: 595–602. 
Exclude by fulltext; no 
intervention for WSLs. 
292 
Artun J, Thylstrup A. A 3-year clinical and SEM study of surface changes of carious enamel lesions after inactivation. 
Am J Orthod Dentofac Orthop 1989; 95: 327–333. 
Exclude by fulltext; no 
intervention for WSLs. 
293 
Holmen L, Thylstrup A, A ° rtun J. Surface changes during the arrest of active enamel carious lesions in vivo. A 
scanning electron microscope study. Acta Odontol Scand 1987; 45: 383–390. 
Exclude by fulltext; no 
intervention for WSLs. 
294 
Mattousch TJ, Van Der Veen MH, Zentner A. Caries lesions after orthodontic treatment followed by quantitative light-
induced fluorescence: a 2-year follow-up. Eur J Orthod 2007; 29: 294–298. 
Exclude by fulltext; no 
intervention for WSLs. 
295 
Øgaard B, Ten Bosch JJ. Regression of white spot enamel lesions. A new optical method for quantitative longitudinal 
evaluation in vivo. Am J Orthod Dentofacial Orthop 1994;106:238-42. 
Exclude by fulltext; no 
intervention for WSLs. 
296 
van der Veen MH, Mattousch T, Boersma JG (2007). Longitudinal development of caries lesions after orthodontic 
treatment evaluated by quantitative lightinduced fluorescence. Am J Orthod Dentofacial Orthop 131:223-228. 
Exclude by fulltext; no 
intervention for WSLs. 
297 Akin M, Basciftci FA. Can white-spot lesions be treated effectively? Angle Orthod 2012;82(5):770-775. 
Exclude by fulltext; not a 
randomized trial. 
298 
Croll TP, Bullock GA. Enamel microabrasion for removal of smooth surface decalcification lesions. J Clin Orthod 
1994;28: 365-70. 
Exclude by fulltext; not a 
randomized trial. 
299 
Kim S, Kim EY, Jeong TS, Kim JW. The evaluation of resin infiltration for masking labial enamel white-spot lesions. Int 
J Paediatr Dent 2011;21(4):241-248. 
Exclude by fulltext; not a 
randomized trial. 
300 
Kleber CJ, Milleman JL, Davidson KR, Putt MS, Triol CW, Winston AE. Treatment of orthodontic white spot lesions 
with a remineralizing dentifrice applied by toothbrushing or mouth trays. J Clin Dent. 1999;10(1 spec no):44–49. 
Exclude by fulltext; not a 
randomized trial. 
301 
Murphy TC, Willmot DR, Rodd HD. Management of postorthodontic demineralized white lesions with microabrasion: a 
quantitative assessment. American journal of orthodontics and dentofacial orthopedics 2007; (1):27-33. 
Exclude by fulltext; not a 
randomized trial. 
302 
[No authors included] {NCT01059058} Study of Treatments Used for White Spot Lesions After Orthodontic Treatment. 
Status: Completed. 
Exclude by fulltext; trial 
registered and completed, 
but not yet published; no 
response from trialists. 
303 
[No authors included] {NCT01329731} Remineralisation of White Spot Lesions by Elmex® gelée in Post-orthodontic 
Patients. Status: Completed. 
Exclude by fulltext; trial 
registered and completed, 
but not yet published; no 
response from trialists. 
304 
[No authors included] {NCT00670618} A Prospective, Randomized Clinical Study on the Effects of Casein 
Phosphopeptide-amorphous Calcium Phosphate (CPP-ACP) Paste on Plaque, Gingivitis and White Spot Lesions in 
Orthodontic Patients - Part 2. Status: Recruiting. 
Exclude by fulltext; 
ongoing trial. 
305 
[No authors included] {NCT00670670} A Prospective, Randomized Clinical Study on the Effects of Casein 
Phosphopeptide-amorphous Calcium Phosphate (CPP-ACP) Paste on Plaque, Gingivitis and White Spot Lesions in 
Orthodontic Patients - Part 1. Status: Recruiting. 
Exclude by fulltext; 
ongoing trial. 
306 
[No authors included] {NCT01344473} A Trial of Tooth Mousse to Remineralise Post-orthodontic Treatment White 
Spot Lesions. Status: Completed. 
Exclude by fulltext; 
ongoing trial. 
307 [No authors included] {NCT01500187} Fluoride Varnish for Treatment of White Spot Lesions. Status: Completed. 
Exclude by fulltext; 
ongoing trial. 
308 
Artun J, Thylstrup A. Clinical and scanning electron microscopic study of surface changes of incipient caries lesions 
after debonding. Scand J Dent Res 1986; 94: 193–201. 
Exclude by fulltext; fulltext 
could not be retrieved. 
309 
Croll TP, Cavanaugh RR. Enamel color modification by controlled hydrochloric acid-pumice abrasion. I. Technique and 
examples. Quintessence Int 1986;17:81-7. 
Exclude by fulltext; fulltext 
could not be retrieved. 
310 
Zhou CH, Sun XH, Zhu XC. [Quantification of remineralized effect of casein phosphopeptiode-amorphous calcium 
phosphate on post-orthodontic white spot lesion]. Shanghai Kou Qiang Yi Xue. 2009 Oct;18(5):449-54. 
Exclude by fulltext; fulltext 
could not be retrieved. 
311 
Agarwal A, Pandey H, Pandey L, Choudhary G. Effect of Fluoridated Toothpaste on White Spot Lesions in 
Postorthodontic Patients. Int J Clin Pediatr Dent 2013;6(2):85-88. 
Included 
312 
Aljehani A, Yousif MA, Angmar-Mansson B, Shi XQ. Longitudinal quantification of incipient carious lesions in 
postorthodontic patients using a fluorescence method. Eur J Oral Sci 2006;114(5):430-4. 
Included 
313 
Andersson A, Skold-Larsson K, Hallgren A, Petersson LG, Twetman S. Effect of a dental cream containing amorphous 
cream phosphate complexes on white spot lesion regression assessed by laser fluorescence. Oral health & preventive 
dentistry. 2007;5(3):229-33. 
Included 
314 
Baeshen HA, Lingstrom P, Birkhed D. Effect of fluoridated chewing sticks (Miswaks) on white spot lesions in 
postorthodontic patients. Am J Orthod Dentofac Orthop 2011;140(3):291-7. 
Included 
315 Bailey DL, Adams GG, Tsao CE, Hyslop A, Escobar K, Manton DJ, et al. Regression of post-orthodontic lesions by a Included 
 remineralizing cream. J Dent Res 2009;88(12):1148-53. 
316 
Beerens MW, van der Veen MH, van Beek H, ten Cate JM. Effects of casein phosphopeptide amorphous calcium 
fluoride phosphate paste on white spot lesions and dental plaque after orthodontic treatment: a 3-month follow-up. Eur 
J Oral Sci 2010;118(6):610-7. 
Included 
317 
Brochner A, Christensen C, Kristensen B, Tranaeus S, Karlsson L, Sonnesen L, et al. Treatment of post-orthodontic 
white spot lesions with casein phosphopeptide-stabilised amorphous calcium phosphate. Clin Oral Invest 
2011;15(3):369-73. 
Included 
318 
Clark SE. Remineralization effectiveness of MI Paste Plus - a clinical pilot study. Master thesis, University of Iowa, 
2011. 
Included 
319 
Cronan CA. Clinical evaluation of treatment of white spot lesions with Icon. Master thesis, University of Alabama, 
2012. 
Included 
320 
Du M, Cheng N, Tai B, Jiang H, Li J, Bian Z. Randomized controlled trial on fluoride varnish application for treatment 
of white spot lesion after fixed orthodontic treatment. Clin Oral Invest 2012;16(2):463-8. 
Included 
321 
Eckstein A, Helms HJ, Knösel M. Camouflage effects following resin infiltration of postorthodontic white-spot lesions in 
vivo: One-year follow-up. Angle Orthod. 2015 May;85(3):374-80. 
Included 
322 
Eckstein A. Ausmaß und Beständigkeit der ästhetischen Verbesserung von Multibrackettherapie-induzierten White-
Spot-Läsionen nach Icon-Infiltration-eine prospektive, randomisierte, splitmouth-kontrollierte klinische Studie. Doctoral 
Dissertation, University of Göttingen, 2013. 
Included 
323 
He T, Li X, Dong Y, Zhang N, Zhong Y, Yin W, Hu D. Comparative assessment of fluoride varnish and fluoride film for 
remineralization of postorthodontic white spot lesions in adolescents and adults over a 6-month period: A single-
center, randomized controlled clinical trial. Am J Orthod Dentofacial Orthop. 2016 Jun;149(6):810-9. 
Included 
324 
Huang GJ, Roloff-Chiang B, Mills BE, Shalchi S, Spiekerman C, Korpak AM, et al. Effectiveness of MI Paste Plus and 
PreviDent fluoride varnish for treatment of white spot lesions: a randomized controlled trial. Am J Orthod Dentofac 
Orthop 2013;143(1):31-41. 
Included 
325 
Jumanca D, Galuscan A, Podariu AC, Ardelean L, Rusu LC. Infiltration Therapy - an Alternative to Fluoride Varnish 
Application for Treatment of White Spot Lesion After Fixed Orthodontic Treatment. Rev Chim 2012;63:783-786. 
Included 
326 
Knosel M, Attin R, Becker K, Attin T. External bleaching effect on the color and luminosity of inactive white-spot 
lesions after fixed orthodontic appliances. Angle Orthod 2007;77(4):646-52. 
Included 
327 
Knosel M, Eckstein A, Helms HJ. Durability of esthetic improvement following Icon resin infiltration of multibracket-
induced white spot lesions compared with no therapy over 6 months: a single-center, split-mouth, randomized clinical 
trial. Am J Orthod Dentofac Orthop 2013;144(1):86-96. 
Included 
328 
Miresmaeili A, Darban H, Mahjub H, Yosefi F, Mollabashi V. Effect of Fluoride Varnish on Improvement of Surface 
Decalcifications after Fixed Orthodontic Treatment. Avicenna Journal of Dental Research. 4(2): 15-23. 
Included 
329 
Seibold LA. Das Einfluss von wöchentlichen 1,25%igen Fluorid- oder Placebogel-Anwendungen auf die Entwicklung 
von Initialkaries-Läsionen nach Multibracket-Behandlung. Doctoral Thesis, University of Giessen, 2015. 
Included 
330 
Senestraro SV, Crowe JJ, Wang M, Vo A, Huang G, Ferracane J, et al. Minimally invasive resin infiltration of arrested 
white-spot lesions: a randomized clinical trial. Journal of the American Dental Association (1939). 2013;144(9):997-
1005. 
Included 
331 
Shell ER. Effectiveness of Mi PasteTM, Mi Paste PlusTM, and Topex RenewTM in remineralization and visible 
reduction of white spot lesions after orthodontic treatment - a clinical study. Master thesis, University of Iowa, 2012. 
Included 
332 
Willmot DR. White lesions after orthodontic treatment: does low fluoride make a difference? Journal of orthodontics. 
2004;31(3):235-42. 
Included 
WSL, white spot lesion; ortho-Tx, orthodontic treatment. 
  
 Supplementary material 4. Detailed risk of bias assessment for the included trials. 
AA Trial 
Sequence 
generation 
Allocation 
concealment 
Blinding of participants/ 
personnel 
Blinding of outcome 
assessors 
Incomplete outcome data 
Selective outcome 
reporting 
Other sources of bias 
1 
Agarwal 
2013 
Unclear – ―…in a 
double-blind, 
randomized, 
longitudinal trial…‖ 
Unclear – No 
mention throughout 
the paper. 
Unclear – the trial is 
described as double-
blind, but no effective 
blinding measure is 
described. 
High risk – no mention of 
blinding throughout the 
paper; blinding should be 
possible. 
Low risk – No drop-outs 
or patient losses are 
reported 
High risk – It is 
difficult to judge 
whether selective 
reporting is a 
problem, as no 
protocol exists; 
however, no data is 
adequately 
reported in the 
published report. 
Unclear – intervention is self-
administered by the patient and 
compliance with the instructions 
not assessed in the study; 
additionally, it is not clear 
whether clustering of 
measurements has been 
adequately assessed in the 
analyses. 
2 
Aljehani 
2006 
Low risk - „The 
subjects were 
randomly assigned 
to one of the two 
groups by using a 
random number 
table― 
Unclear – No 
mention throughout 
the paper. 
Unclear - Blinding is 
feasible for 
patients/orthodontist; both 
objective and subjective 
outcomes are included 
and blindly not 
adequately described as 
blind for all cases: „The 
subjects and the dental 
assistant were aware of 
the group assignment, 
which was unavailable to 
the examiner―. 
Unclear –„The subjects and 
the dental assistant were 
aware of the group 
assignment, which was 
unavailable to the examiner―; 
however, blinding is not 
completely described, while 
both subjective and objective 
outcomes are included. 
Low risk - No drop-outs 
or patient losses are 
reported. 
High risk – It is 
difficult to judge 
whether selective 
reporting is a 
problem, as no 
protocol exists; 
however, no data is 
adequately 
reported in the 
published report. 
Unclear – intervention is self-
administered by the patient and 
compliance with the instructions 
not assessed in the study. 
3 
Anderss
on 2007 
Low risk - „The 
patients were 
randomly assigned 
with a dice to one of 
two 6-month 
treatment regimes― 
 
Unclear – No 
mention throughout 
the paper. 
Unclear - Blinding was 
feasible for 
patients/orthodontist; 
outcome is objective and 
assessed blindly. 
Low risk - Blinding of 
outcome assessor: ―The 
clinical recordings were 
performed by one blinded 
examiner (AA) who was 
calibrated before the start of 
the study. The examiner 
could not see the previous 
registered clinical scores or 
LF values at the follow-up 
sessions‖. 
Low risk - „One male in 
group B was lost during 
follow-up due to 
relocation―: one drop-out, 
which was considered to 
be random and minor. 
Unclear – It is 
difficult to judge 
whether selective 
reporting is a 
problem, as no 
protocol exists. 
 
High risk – intervention is self-
administered by the patient, but 
compliance with the instructions 
was assessed in the study and 
considered similar in the two 
groups; however, clustering of 
measurements has been 
disregarded in the analyses; 
additionally, the one intervention 
was used for the half of the study 
period (3 mos), while the second 
was used for the whole period (6 
mos). 
4 
Baeshe
n 2011 
Low risk - „The 
participants were 
randomly divided 
based on a 
randomization list 
into 2 groups―. 
Unclear – No 
mention throughout 
the paper. 
Unclear – ―The 
participants and the 
examiner were not aware 
of the group assignments, 
not even the covered or 
noncovered side―: 
blinding of the personell 
and patient could be 
performed as intervention 
is self-administered and 
the two miswaks were 
Low risk – blinding of 
outcome assessors was 
undertaken (see previous 
domain). 
Low risk - No drop-outs 
or patient losses are 
reported. 
Unclear – It is 
difficult to judge 
whether selective 
reporting is a 
problem, as no 
protocol exists. 
 
High risk – intervention is self-
administered by the patient and 
compliance with the instructions 
not assessed in the study; 
additionally, clustering of 
measurements has been 
disregarded in the analyses. 
 identical: ―The 2 types of 
miswaks were identical 
except for their fluoride 
content‖; however, only 
blinding of the 
participants was 
undertaken. 
5 
Bailey 
2009 
Low risk – ―The 
paricipants were 
allocated to one of 
the two study 
products, according 
to a computer-
generated random 
permuted blocks 
schedule (blocks of 
four and six)‖. 
Low risk – central 
allocation: ―blinded 
product packages 
prepared by non-
clinical staff labeled 
with a 3-digit code 
and visit number, 
study products were 
supplied in identical 
packaging with no 
observable 
difference in 
appearance, taste or 
smell‖. 
Low risk – complete 
blinding feasible and 
undertaken; see 
allocation concealment 
text. 
Low risk – complete blinding 
feasible and undertaken; see 
allocation concealment text; 
also ―The randomization 
schedule 
was secured and released 
only upon completion of all 
data collection and database 
lock‖. 
Low risk – all 
randomized patients were 
analyzed at the final 
timepoint; minor drop-
outs for intermediate 
time-points were 
negligible. 
Low risk – trial has 
been registered in 
ANZCTR and 
although some 
minor points exist 
(outcome 
measurement 
procedure changes 
during trial due to 
technique 
sensitivity; 
retrospective 
registration), the 
risk of bias was 
judged as low. 
Low risk – intervention is self-
administered by the patient, but 
compliance with the instructions 
was assessed in the study: 
―Product tubes were weighed 
prior to dispensation and on 
return from the participant. 
Overall compliance was 
calculated as the total amount of 
study product used‖; clustering of 
measurements has been taken 
into account in the analyses. 
6 
Beeren
s 2010 
Low risk - Subjects, 
complying with the 
inclusion criteria 
determined by 
M.W.B., were then 
randomly assigned 
by M.H.V. to either 
the CPP-ACFP 
group or the control 
group, as 
determined by a 
computer-
randomization 
scheme that was 
created and locked 
before the start of 
the study.  
 
Unclear – allocation 
concealment 
unclear; not clear 
how the person 
randomizing patients 
(MHV) was involved 
in the study, 
although she 
probably did not 
have to do anything 
with the clinical 
procedures. 
Low risk - double-blind; 
complete blinding feasible 
and undertaken; „The 
subjects received neutral-
coloured toothpaste tubes 
marked A or B, which 
contained either CPP-
ACP + sodium fluoride―.  
 
Low risk – ―The images were 
captured by several 
examiners who were 
calibrated before the start of 
the investigation and who 
were blinded with respect to 
the treatment group …..The 
QLF images obtained for 
each subject were analysed 
blind with regard to treatment 
group; the group allocations 
were added to the exported 
data after completion of all 
analyses―. 
Unclear - ―a total of ten 
participants dropped out 
between T0 and T3, 
seven from the CPP-
ACFP group and three 
from the control group. 
The reason given for 
withdrawal was the time-
consuming nature of the 
study. One further 
participant from the CPP-
ACFP group was found to 
be WSL free and was 
removed from the study. 
These participants did not 
differ with respect to 
number of lesions, gender 
ratio, age, and 
MB treatment duration 
compared with subjects 
who completed the 
study.‖: a small-to-
moderate number of 
patients (15%) left the 
study; although the 
authors report that the 
reasons didn’t have to do 
with the allocated group, 
Unclear – It is 
difficult to judge 
whether selective 
reporting is a 
problem, as no 
protocol exists. 
 
Low risk – intervention is self-
administered by the patient, but 
compliance with the instructions 
was assessed in the study: 
―Compliance was checked by 
questions asked on each visit 
about the frequency of tooth 
brushing and application of the 
study paste and how often, 
and when these were forgotten. 
Furthermore, subjects were 
asked to bring their study paste 
on each visit.‖; clustering of 
measurements has been taken 
into account in the analyses. 
 the dropped patients were 
not equally distributed in 
groups and no formal 
analysis was reported. 
7 
Brochn
er 2011 
Low risk – ―The 
subjects were 
allocated to one of 
the two groups as 
determined with aid 
of computer 
randomization‖. 
Unclear – No 
mention throughout 
the paper. 
High risk - Blinding was 
feasible for 
patients/orthodontist, but 
was not 
undertaken/described. 
Low risk – ―The researchers 
responsible for the study and 
evaluating the endpoints 
were not involved in the 
clinical work and blinded for 
the group assignment‖: 
although blinding not 
completely described, it was 
judged as adequate.  
High risk – ―It should 
also be stressed that the 
dropout numbers were 
comparatively high (20–
25%) also for the visual 
readings due to technical 
problems. ― 
 
Unclear – It is 
difficult to judge 
whether selective 
reporting is a 
problem, as no 
protocol exists. 
 
Low risk – intervention is self-
administered by the patient, but 
compliance with the instructions 
was assessed in the study: 
―Based on the personal 
interviews, we had all reasons to 
believe that 
the subjects complied with the 
study protocol‖; clustering of 
measurements has been taken 
into account in the analyses. 
8 
Clark 
2011 
High risk – 
allocation method 
not truly random: 
―The first six patients 
who met the study 
criteria were 
selected for the 
treatment group. 
The following six 
patients 
who again met the 
study criteria were 
selected to be the 
control subjects―. 
Unclear – No 
mention throughout 
the paper. 
High risk - Blinding was 
feasible for 
patients/orthodontist, but 
was not 
undertaken/described. 
High risk – no mention of 
blinding throughout the 
paper; blinding should be 
possible. 
Low risk – No drop-outs 
are being reported. 
Unclear – It is 
difficult to judge 
whether selective 
reporting is a 
problem, as no 
protocol exists. 
 
High risk – intervention is self-
administered by the patient and 
compliance with the instructions 
not assessed in the study; 
additionally, clustering of 
measurements has been 
disregarded in the analyses. 
9 
Cronan 
2012 
Unclear – 
―Treatment and 
control sides were 
divided up by 
randomly assigning 
patients to either the 
right or left side 
treatment group 
upon enrollment in 
the study.‖ 
Unclear – No 
mention throughout 
the paper 
Unclear – no mention of 
patients’/orthodontists’ 
blinding throughout the 
paper; blinding is 
impractical for the 
clinician, but should be 
possible for the patient. 
Low risk – ―All lesions were 
scored by a single examiner 
who was blinded to timepoint 
and group assignment‖: 
description vague, but 
blinding was judged to be 
possible correctly used. 
Low risk – No drop-outs 
or patient losses are 
reported 
Unclear – It is 
difficult to judge 
whether selective 
reporting is a 
problem, as no 
protocol exists. 
 
Unclear – intervention is 
administered by the clinician, so 
compliance is not a problem; 
however, it is not clear if 
additional bias could have been 
introduced by the inclusion of 
patients that had been debonded 
during the last 0.5-14 years (in 
these patients, an initial 
remineralization through saliva 
and fluoride toothpaste has 
already taken place)—although 
this was attemped to be 
controlled for in the analyses 
(cut-off of 4 months), the 
intervention might not work the 
same in fresh and old WSLs; 
additionally, it is not clear 
whether clustering of 
measurements has been 
adequately assessed in the 
 analyses (unclear GEE analysis 
description); finally considerably 
more WSL exist than other 
studies and no explanation is 
given for this. 
10 
Du 
2012 
Low risk – ―Using a 
random number 
table, the 
participants were 
assigned to either 
the test group or the 
placebo group‖. 
Low risk – 
―Randomization was 
performed by a 
researcher not 
involved in the 
study‖. 
Unclear – no mention of 
patients’/orthodontists’ 
blinding throughout the 
paper; blinding is 
impractical for the 
clinician, but should be 
possible for the patient; 
although not explicitly 
stated, the use of saline 
solution for the control 
group indicates a possible 
degree of blinding. 
Low risk – ―The 
assessments in all visits were 
carried out by the same 
dentist who was blind as to 
group allocation of the 
subjects‖. 
Unclear – 14 (13%) 
dropouts; due to harsh 
criteria (―subjects who 
missed one or more visits 
were regarded as dropout 
(non-compliant patients‖). 
No description given 
about the allocation of the 
drop-outs and no 
assessment in the 
analysis of this factor. 
Unclear – It is 
difficult to judge 
whether selective 
reporting is a 
problem, as no 
protocol exists. 
 
Unclear – intervention is 
administered by the clinician, so 
compliance is not a problem; 
however, clustering of 
measurements has been 
disregarded in the analyses. 
11 
Eckstei
n 2013; 
Knosel 
2013; 
Eckstei
n 2015 
Low risk – ―Simple 
randomized cluster 
(quadrant) allocation 
was performed by lot 
before the start of 
the trial by the 
second author.‖ 
Low risk – ―the 
allocations were 
concealed in opaque 
envelopes (lots) by a 
person not 
connected with this 
study.‖ 
Unclear - Blinding is 
impractical for both 
patients and clinician; 
outcome is objective, but 
was not assessed blindly. 
High risk – ―there was no 
blinding of the assessor to 
the intervention or the control 
quadrants.‖ 
Low risk – minor 
dropouts: ―One droupout 
because of missing to 
four appointments‖. 
Unclear – It is 
difficult to judge 
whether selective 
reporting is a 
problem, as no 
protocol exists. 
Unclear – intervention is 
administered by the clinician, so 
compliance is not a problem; 
additionally, clustering of 
measurements is not an issue; 
however, it is not clear if 
additional bias could have been 
introduced by the inclusion of 
patients that had been debonded 
between 1-12 months before 
(mean 5.1 months; in patients 
with a considerable elapsed time, 
an initial remineralization through 
saliva and fluoride toothpaste has 
taken place); additionally,it is not 
clear whether analyses were 
performed after commencement 
and before completion (―Sample 
size calculation (…) based on 
completed assessment cycles of 
the first 13 subjects indicated that 
20 subjects (each with a mean of 
8.3 trial teeth)‖; which could 
introduce bias. 
12 
He 
2016 
Low risk – 
―Randomization was 
accomplished using 
Excel (Microsoft) 
software for simple 
randomization.‖. 
Low risk – ―After the 
schedule was 
made, group 
assignment 
information was 
written on 
cards and concealed 
in nontransparent 
envelopes with 
Unclear - Blinding is 
impractical for both 
patients and clinician; 
however, outcome is 
objective and assessed 
blindly. 
Low risk – ―Additionally, the 
examiners who conducted 
the imaging acquisition and 
the analysis of the images 
were blinded to the 
intervention allocation… a 
unique subject identifier was 
allocated…‖ 
Low risk – Minor drop-
outs and full data are 
given about the 
characteristics of the 
drop-outs. 
Low risk – trial 
protocol registered 
prospectively and 
available online. No 
considerable 
changes to the 
protocol were 
found (also ―No 
changes were 
Low risk – intervention is 
administered by the clinician, so 
compliance is not a problem; 
additionally, clustering of 
measurements is not an issue. 
 sequential numbers 
on the outside to 
achieve allocation 
concealment. The 
generation of a 
random allocation 
sequence and the 
preparation of the 
cards and envelopes 
were finished well 
before patient 
recruitment by an 
author (Y.Z.).‖ 
made after trial 
commencement)‖. 
13 
Huang 
2013 
Low risk – ―The 
randomization 
sequence was 
created by using 
statistical software 
(axio research) and 
was stratified by 
each office by using 
random block sizes 
of 3 and 6.‖ 
Low risk – 
Allocation sequence 
was concealed from 
the office during 
enrollment. To 
receive the patient’s 
treatment 
assignment the NW 
PRECEDENT office 
phoned Axio 
Research. 
Unclear - Blinding is 
impractical for both 
patients and clinician; 
however, outcome is 
objective and assessed 
blindly. 
Low risk – ―Two panels 
consisting of 5 dental 
professionals and 5 
laypersons assessed the 
before-and-after pairs of 
photographs in a blinded 
fashion‖ and ―Two blinded 
examiners performed the 
objective assessment of the 
WSLs. The outcome 
assessors and the study 
investigators were kept 
blinded to the study arms 
until completion of the 
statistical analyses‖ 
Low risk – ―Twenty 
participants withdrew or 
were lost to follow-up 
between the start and the 
end of the study, 
including 11 from the MI 
Paste Plus group, 
2 from the PreviDent 
group, and 7 from the 
home-care 
control group. They did 
not vary with respect to 
demographic data and 
initial WSL severity 
compared with the 
subjects who completed 
the study.‖. 
Low risk – trial 
protocol registered 
prospectively and 
available online. No 
considerable 
changes to the 
protocol were 
found. 
Unclear – intervention is either 
administered by the clinician, so 
compliance is not a problem or it 
compliance has been assessed 
(―Compliance was checked by 
questions at the follow-up visit 
about the frequency 
of application of the MI Paste 
Plus.‖); additionally, clustering of 
measurements is not an issue; 
however, it is not clear if 
additional bias could have been 
introduced by the inclusion of 
patients that had been debonded 
during the last two months (in 
these patients, an initial 
remineralization through saliva 
and fluoride toothpaste has taken 
place). 
14 
Jumanc
a 2012 
Unclear – ―The 
remaining 60 
patients, were 
randomly divided in 
3 groups and 
received different 
therapeutic conduct, 
as follows:..‖ 
Unclear – No 
mention throughout 
the paper. 
Unclear – no mention of 
blinding throughout the 
paper; blinding is 
impractical for both 
patient and clinician. 
High risk – no mention of 
blinding throughout the 
paper; blinding should be 
possible 
High risk – Two drop-
outs caused by too high 
DiagnoDent pen values; 
the number of drop-outs 
is per se small, but the 
justification is 
inappropriate. 
High risk – It is 
difficult to judge 
whether selective 
reporting is a 
problem, as no 
protocol exists; 
however, patient 
satisfaction is 
mentioned on page 
785, but no further 
data are given; 
additionally, results 
about randomized 
group 3 are not 
given at all. 
Unclear – intervention is 
administered by the clinician, so 
compliance is not a problem 
however it is not clear if 
clustering of measurements is an 
issue; furthermore, several 
important information of the trial 
(including results of a randomized 
group) are missing. 
15 
Knosel 
2007 
Unclear – ―Nineteen 
patients with inactive 
WSLs after therapy 
Unclear – No 
mention throughout 
the paper. 
Unclear - Blinding is 
impractical for both 
patients and clinician; 
High risk – no mention of 
blinding throughout the 
paper; blinding should be 
Low risk – No drop-outs 
or patient losses are 
reported 
High risk – It is 
difficult to judge 
whether selective 
Unclear – intervention is 
administered by the clinician, so 
compliance is not a problem; 
 with fixed 
orthodontic 
appliances were 
selected and 
randomly placed into 
two groups‖. 
however, outcome is 
objective and assessed 
blindly. 
possible. All determinations 
were performed by the same 
operator. 
reporting is a 
problem, as no 
protocol exists; 
results of at least 
one measured 
outcome (patient 
satisfaction 
questionnaire) 
have not been 
adequately 
reported. 
however clustering of 
measurements has been 
disregarded in the analyses. 
16 
Miresm
aeili 
2012 
Low risk – ―After 
selection of 20 
patients, 10 were 
allocated to the test 
and the remaining 
10 to the control 
group using the 
random numbers 
table.‖ 
Unclear – No 
mention throughout 
the paper. 
Unclear - Blinding is 
impractical for both 
patients and clinician; 
outcome is objective, but 
was not assessed blindly. 
Unclear – no mention of 
blinding throughout the 
paper; blinding should be 
possible. 
Low risk – No drop-outs 
or patient losses are 
reported. 
High risk – It is 
difficult to judge 
whether selective 
reporting is a 
problem, as no 
protocol exists; 
data not reported in 
adequate detail . 
Unclear – intervention is 
administered by the clinician, so 
compliance is not a problem; 
however, clustering of 
measurements has been 
disregarded. 
17 
Seibold 
2015 
Low risk – patient 
assignment was 
randomized through 
the assignments of 
numbers from a 
random numbers list. 
Unclear – sealed 
envelopes used; 
unclear if opaque. 
Unclear - Blinding is 
impractical for both 
patients and clinician; 
however, outcome is 
objective and assessed 
blindly. 
Low risk – blinding 
throughout the study until 
after the assesement of the 
data 
Low risk – Two drop-outs 
were replaced during the 
first week. A total of 15% 
of the enrolled patients 
were lost ultimately, but 
this was assessed by 
comparison ―per protocol‖ 
and ―intention-to-treat‖ 
approaches. 
Unclear – some 
amendments 
(mainly pertaining 
to the outcome 
measurement 
timepoints and 
primary outcome 
measure) are 
described, but it 
was judged that 
these should not 
introduce any bias . 
Unclear – it is unclear if any trial 
violations existed, as the authors 
state that the sealed envelopes 
with the patient allocation were 
available in the study center for 
emergencies; emergencies are 
referenced in the text, but are 
neither listed nor explicitly 
excluded. 
18 
Senestr
aro 
2013 
Unclear – ―For each 
participant, we used 
an electronic 
random number 
generator to select 
one affected tooth to 
serve as a control 
(no treatment), and 
we assigned the 
remaining teeth to 
the treatment group. 
Owing to reports of 
variable responses 
to reatment,27,28 
allocation of teeth 
was biased toward 
the treatment group 
to maximize the 
Unclear – No 
mention throughout 
the paper. 
Unclear - Blinding is 
impractical for both 
patients and clinician; 
outcome is subjective, but 
was assessed blindly. 
Low risk – Masking of all 
raters has been undertaken:  
the slides shown to the 
assessors were randomly 
sequenced. The lead 
investigator encoded image 
file names to mask the time 
point of the image. Another 
investigator outlined and 
measured WSL areas. 
Unclear – a very high 
drop-out rate was seen 
(33%), while the study, 
although split-mouth 
seems not to be 
adequately balanced, as 
46 and 20 teeth were 
allocated to the 
experimental and the 
control group; no further 
characteristics of the 
drop-outs are given. 
Unclear – It is 
difficult to judge 
whether selective 
reporting is a 
problem, as no 
protocol exists. 
Unclear – intervention is 
administered by the clinician, so 
compliance is not a problem; 
however, clustering of 
measurements has been 
disregarded. 
 number of teeth 
treated‖: although 
allocation seems 
random, description 
is not adequate to 
ensure that no bias 
could have been 
introduced. 
19 
Shell 
2012 
High risk – non-
random allocation of 
patients: ―The 
control and MI Paste 
Plus In Office 
treatment groups 
were filled first, one 
patient assigned to 
each group in an 
alternating manner 
until filled both 
groups were filled as 
evenly as possible. 
Then the same 
procedure happened 
with the groups 
using only at-home 
protocols‖ 
Unclear – No 
mention throughout 
the paper 
Unclear - Blinding is 
impractical for both 
patients and clinician; 
outcome is objective, but 
was not assessed blindly. 
High risk – no mention of 
blinding throughout the 
paper, blinding could have 
been implemented 
Low risk – no drop-outs 
or patient loss reported. 
Unclear – It is 
difficult to judge 
whether selective 
reporting is a 
problem, as no 
protocol exists. 
Unclear – intervention is self-
administered by the patient, but 
compliance with the instructions 
assessed in the study (―the same 
detailed oral and written 
instructions to each patient upon 
enrollment was an 
effort to standardized application 
across patient and treatment 
groups, as was the distribution 
and collection of at-home diary 
cards, which all patients 
returned.‖); however, clustering of 
measurements has been 
disregarded in the analyses. 
20 
Willmot 
2004 
Low risk – ―Packs of 
mouthrinse and 
toothpaste were 
numbered and 
randomized by the 
dental products 
company according 
to a table of random 
numbers‖. 
Low risk – ―Packs 
were 
numbered 1 
onwards by the 
pharmaceutical 
company and 
the test/control 
packs were 
randomized by that 
company 
according to a table 
of random numbers 
held by the 
company. The code 
was placed in a 
sealed envelope 
until the conclusion 
of both the trial and 
measurements‖: 
although opacity not 
stated, transparency 
measures adopted 
through central 
allocation were 
Low risk – quadruple-
blind: ―Participants and 
researcher were unaware 
as to whether an 
intervention or control 
mouthrinse was being 
supplied. 
Low risk – quadruple-blind: 
―The test and control 
interventions content were 
unknown to the researcher at 
imaging and measurement. ― 
and ―The curves for the study 
were calculated and 
produced before the 
andomization code was 
unlocked‖. 
Low risk – 5 (19%) 
dropouts because of 
subsequently failing to 
attend for any further 
appointments; however, 
distribution of drop-outs in 
the groups is similar and 
it is unlikely that any 
differences in the two 
experimental groups 
would be responsible for 
dropouts. 
Unclear – It is 
difficult to judge 
whether selective 
reporting is a 
problem, as no 
protocol exists. 
Low risk – intervention is self-
administered by the patient, but 
compliance with the instructions 
assessed in the study 
(―Participants were instructed to 
keep all empty bottles and tubes, 
and return them to the researcher 
at their next 
visit‖); clustering of 
measurements in the analyses is 
not an issue; selection of 
assessed lesions per patients 
seems random and therefore was 
judged not to be prone to bias. 
 judged adequate. 
  
 
  
 Supplementary material 5. Details of the GRADE assessment for the main outcomes of this systematic review. 
Outcome Risk of Bias Inconsistency 
Indirect
ness 
Imprecision 
Publicatio
n bias 
Large 
Effect 
Dose 
Response 
Residual 
Confounding 
Outc 1: 
lesion 
area. 
Starts from "high", due to the inclusion of 
randomized studies. There exists moderate 
risk of bias from methodological limitations 
of included trials; however, the sensitivity 
analysis excluding trials with high risk of 
bias did not find discordant results.  
High heterogeneity, which affects 
both the decision for/against the 
intervention and the precision for 
this estimate; large part of the 
heterogeneity has been explained 
through subgroup analysis. 
Directly 
relevant 
Inadequate 
sample; the 95% 
CI includes both 
the null effect and 
small negative 
values, which 
indicates 
imprecision. 
No 
assessmen
t possible. 
No 
reason 
to rate 
up 
No dose 
response 
assessme
nt. 
Cannot be 
ruled out. 
Outc 2: 
lesion 
fluoresce
nce. 
Starts from "high", due to the inclusion of 
randomized studies. There exists moderate 
risk of bias from methodological limitations 
of included trials; however, the sensitivity 
analysis excluding trials with high risk of 
bias did not find discordant results.  
High heterogeneity, which affects 
both the decision for/against the 
intervention and the precision for 
this estimate; large part of the 
heterogeneity has been explained 
through subgroup analysis and 
measurement method. 
Same as 
lesion 
area. 
Inadequate 
sample; the 95% 
CI includes both 
the null effect and 
moderate to large 
negative values, 
which indicates 
imprecision. 
Same as 
lesion area. 
Same 
as 
lesion 
area. 
Same as 
lesion 
area. 
Same as 
lesion area. 
Outc 3: 
lesion 
improvem
ent/regres
sion. 
Starts from "high", due to the inclusion of 
randomized studies. No serious reason to 
downgrade (in 1/3 trials the 
personnel/patients were not blinded; but 
outcome assessment was blind). 
Low heterogeneity; no reason to 
downgrade. 
Same as 
lesion 
area. 
Inadequate 
sample; the 95% 
CI includes both 
the null effect and 
moderate 
positive/negative 
values, which 
indicates 
imprecision. 
Same as 
lesion area. 
Same 
as 
lesion 
area. 
Same as 
lesion 
area. 
Same as 
lesion area. 
Outc, outcome; CI, confidence interval. 
 Supplementary material 6. Results of the subgroup analyses/meta-regressions for meta-analyses with at least three included trials. 
  
WSL area 
 
Fluoresence (QLF/DD) 
 
Invisible /regressed WSLs 
  
n MD 95% CI PSG  
n SMD 95% CI PSG  
n OR 95% CI PSG 
Intervention BG toothpaste 1 -2.59 -4.31,-0.87 0.033 
 
1 -0.02 -0.48,0.45 0.031 
 
- - - 0.633 
 
CPP-ACP 3 -0.05 -0.14,0.04 
  
3 0.02 -0.27,0.31 
  
2 1.10 0.55,2.19 
 
 
CPP-ACP with F 2 -1.43 -1.98,-0.88 
  
2 0.17 -0.16,0.50 
  
- - - 
 
 
F film 1 -0.67 -0.98,-0.36 
  
1 -0.47 -0.69,-0.26 
  
- - - 
 
 
F mouthrinse 1 -0.09 -0.91,0.73 
  
- - - 
  
- - - 
 
 
F varnish 1 -0.80 -1.10,-0.50 
  
3 -0.92 -1.32,-0.52 
  
- - - 
 
 
F gel - - - 
  
- - - 
  
1 0.70 0.30,1.65 
 
 
F miswak - - - 
  
1 -2.04 -2.83,-1.25 
  
- - - 
 
 
Non-F miswak - - - 
  
1 -0.32 -0.97,0.34 
  
- - - 
 
                
Follow-up 
duration 
Per month 
increase 
6 -0.03 -0.43,0.37 0.843 
 
8 -0.20 -0.37,-0.02 0.032 
 
3 0.86 0.05,15.70 0.633 
WSL, white spot lesion; QLF, Quantitative light-induced fluorescence; DD, DIAGNOdent; n, number of included studies; MD, mean difference; CI, confidence interval; PSG; P value for 
differences from subgroup analysis/meta-regression; OR, odds ratio; BG, bioactive glass; CPP-ACP, casein phosphopeptides - amorphous calcium phosphate; F, fluoride. 
  
           
           
       
          
         
PrI not estimable 
with PrI 
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PrI not estimable 
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BG Toothpaste 
Shell 2012 
Subtotal 
CPP-ACP 
Brochner 2011 
Beerens 2010 
Shell 2012 
Subtotal 
CPP-ACP & F 
Clark 2011 
Shell 2012comb 
Subtotal 
F Film 
He 2016-film 
Subtotal 
F Mouthrinse 
Willmot 2004 
Subtotal 
F Varnish 
He 2016-varnish 
Subtotal 
Study 
3 
1 
3 
3 
3 
3 
6 
6.5 
6 
Mos 
-2.59 (-4.31, -0.87) 
-2.59 (-4.31, -0.87) 
-0.05 (-0.14, 0.04) 
 0.10 (-0.85, 1.05) 
-0.81 (-2.27, 0.65) 
-0.05 (-0.14, 0.04) 
-1.66 (-4.35, 1.03) 
-1.42 (-1.98, -0.86) 
-1.43 (-1.98, -0.88) 
-0.67 (-0.98, -0.36) 
-0.67 (-0.98, -0.36) 
-0.09 (-0.91, 0.73) 
-0.09 (-0.91, 0.73) 
-0.80 (-1.10, -0.50) 
-0.80 (-1.10, -0.50) 
MD (95% CI) 
100 
100 
99 
1 
<1 
100 
4 
96 
100 
100 
100 
100 
100 
100 
100 
Weight 
0 -5.0 -4.4 -2.2 -1.1 1.1 2.2 4.4 5.0 
Subgroup 
         (-0.62, 0.52) 
very large large moderate small 
Lesion area (mm2) 
Favors intervention Favors control 
Supplementary material 7. Contour-enhanced forest plot of the treatment effects on white spot lesion area according to the intervention used. Color 
contours indicate increasing effect magnitude from the middle to the ends of the forest plot: small effects (white); moderate effects (light grey); large 
effects (dark grey); and very large effects (darker grey). Mos, months of follow-up; MD; mean difference; CI, confidence interval; comb, combined trial 
arms; and PrI, predictive interval. Studies on the left and the right side of the middle line favor the intervention and the control group, respectively.  
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BG Toothpaste 
Shell 2012 
Subtotal 
CPP-ACP 
Beerens 2010 
Brochner 2011 
Shell 2012 
Subtotal  
CPP-ACP & F 
Clark 2011 
Shell 2012comb 
Subtotal 
F Film 
He 2016-film 
Subtotal 
F Varnish 
Du 2012 
Jumanca 2012 
He 2016-varnish 
Subtotal  
F miswak 
Baeshen 2011 
Subtotal 
Non-F miswak 
Baeshen 2011 
Subtotal 
Study 
3 
3 
1 
3 
3 
3 
6 
6 
6 
6 
1.4 
1.4 
Mos 
QLF 
QLF 
QLF 
QLF 
QLF 
QLF 
QLF 
DD 
DD 
QLF 
DD 
DD 
Method 
-0.02 (-0.48, 0.45) 
-0.02 (-0.48, 0.45) 
 0.13 (-0.06, 0.32) 
 0.16 (-0.40, 0.72) 
-0.34 (-0.80, 0.13) 
 0.02 (-0.26, 0.31) 
 0.12 (-0.45, 0.70) 
 0.19 (-0.21, 0.59) 
 0.17 (-0.16, 0.50) 
-0.47 (-0.68, -0.26) 
-0.47 (-0.68, -0.26) 
-1.25 (-1.55, -0.95) 
-0.74 (-1.38, -0.10) 
-0.72 (-0.94, -0.50) 
-0.92 (-1.32, -0.52) 
-2.04 (-2.83, -1.25) 
-2.04 (-2.83, -1.25) 
-0.32 (-0.97, 0.34) 
-0.32 (-0.97, 0.34) 
SMD (95% CI) 
100 
100 
56 
19 
25 
100 
33 
67 
100 
100 
100 
37 
21 
41 
100 
100 
100 
100 
100 
Weight 
    0 -3 -.5 .5 3 
Subgroup very large large moderate small 
Lesion fluorescence 
Favors intervention Favors control 
Supplementary material 8. Contour-enhanced forest plot of the treatment effects on white spot lesion fluorescence according to the intervention used. Color contours 
indicate increasing effect magnitude from the middle to the ends of the forest plot: small effects (white); moderate effects (light grey); large effects (dark grey); and very 
large effects (darker grey). Mos, months of follow-up; Method, method of outcome measurement; SMD; standardized mean difference; CI, confidence interval; comb, 
combined trial arms; DD, DIAGNOdent; QLF, quantitative light-induced fluorescence; and PrI, predictive interval. Studies on the left and the right side of the middle line 
favor the intervention and the control group, respectively.  
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Supplementary material 9. Meta-regression for the association between change in lesion fluorescence 
[expressed as Standardized Mean Difference (SMD)] and the months of follow-up of each included trial. 
 Supplementary material 10. Details of the performed sensitivity analyses. 
Category Subgroup Lesion area 
 
Lesion fluorescence 
 
Invisible/regressed lesions 
  
n MD 95% CI P 
 
n SMD 95% CI P 
 
n OR 95% CI P 
Measurement 
Photograph (lesion area) / 
DIAGNOdent (lesion fluorescence) 
1 -0.09 -0.91,0.73 0.568 
 
3 -0.88 -1.38,-0.37 0.036 
 
- - - - 
 
QLF 5 -0.56 -1.12,-0.01 
  
5 -0.08 -0.48,0.33 
  
- - - 
 
                
Lesion/patient Per additional lesion/ patient 5 0.15 -0.41,0.71 0.459  7 0.15 -0.04,0.33 0.097  - - - - 
                
Risk of bias Low or unclear 3 -0.38 -0.95,0.18 0.521 
 
3 -0.57 -1.30,0.16 0.363 
 
2 1.12 0.48,2.59 0.722 
 
High 3 -0.86 -2.14,0.42 
  
5 -0.17 -0.48,0.14 
  
1 0.82 0.52,1.28 
 
N, number of studies; MD, mean difference; CI, confidence interval; SMD, standardized mean difference; OR, odds ratio; QLF, quantitative light-induced fluorescence. 
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Supplementary material 11. Meta-regression for the association between change in lesion fluorescence 
[expressed as Standardized Mean Difference (SMD)] and the number of assessed lesions per patient. 
         (-6.59, 4.84) 
         (-1.55, 1.40) 
         (-1.74, 1.04) 
with PrI 
with PrI 
with PrI 
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. 
. 
Overall 
Clark 2011 
Baeshen 2011comb 
Shell 2012comb 
He 2016comb 
Beerens 2010 
Subtotal 
QLF 
DD 
Du 2012 
Study 
Brochner 2011 
Subtotal 
Jumanca 2012 
3 
1.4 
3 
6 
3 
6 
Mos 
1 
6 
-0.35 (-0.75, 0.05) 
 0.12 (-0.45, 0.70) 
-0.50 (-1.06, 0.07) 
-0.06 (-0.42, 0.31) 
-0.62 (-0.81, -0.43) 
 0.13 (-0.06, 0.32) 
-0.88 (-1.38, -0.37) 
-1.25 (-1.55, -0.95) 
SMD (95% CI) 
 0.16 (-0.40, 0.72) 
-0.08 (-0.48, 0.33) 
-0.74 (-1.38, -0.10) 
100 
11 
11 
13 
14 
14 
36 
14 
Weight 
11 
64 
11 
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Subgroup 
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Supplementary material 12. Forest plot for the sensitivity analysis of the meta-analysis on lesion 
fluorescence according to the evaluation method used. 
 Supplementary material 13. GRADE summary of findings table for the sensitivity analyses of this systematic review according to the 
various interventions. 
Outcomes Intervention  
Illustrative comparative effects (95% CI) 
Trials GRADE* 
Significant 
effect Control Intervention 
  
Assumed change Corresponding change 
   
Lesion area BG toothpaste 
Mean lesion shrinkage of 0.37 mm
2
 
in the control groups. 
They shrink by 2.59 mm
2
 more (95% CI: 0.87 to 4.31 
mm
2
 more). 
1 ⊕⊕⊕⊝a,b Yes 
 
CPP-ACP   
They shrink by 0.05 mm
2
 more (95% CI: 0.14 mm2 
more 0.04 mm2 less). 
3 ⊕⊕⊝⊝a,c No 
 
CPP-ACP & F   
They shrink by 1.43 mm
2
 more (95% CI: 0.88 to 1.98 
mm
2
 more). 
2 ⊕⊕⊕⊝a Yes 
 
F film   
They shrink by 0.67 mm
2
 more (95% CI: 0.36 to 0.98 
mm
2
 more). 
1 ⊕⊕⊕⊕ Yes 
 
F mouthrinse   
They shrink by 0.09 mm
2
 more (95% CI: 0.91 mm2 
more 0.73 mm2 less). 
1 ⊕⊕⊕⊝b No 
  F varnish   
They shrink by 0.80 mm
2
 more (95% CI: 0.50 to 1.10 
mm
2
 more). 
1 ⊕⊕⊕⊕ Yes 
  
Assumed change Corresponding change 
 
 
 
Lesion fluorescence BG toothpaste 
Mean enamel fluorescence increase 
by 1.07% in the control groups. 
Fluorescence increases 0.05% more (1.20% more to 
1.13% less) 
1 ⊕⊕⊝⊝a,c No 
 
CPP-ACP   
Fluorescence increases 0.02% less (0.26% more to 
0.31% less) 
3 ⊕⊕⊝⊝a,d No 
 
CPP-ACP & F   
Fluorescence increases 0.17% less (0.16% more to 
0.50% less) 
2 ⊕⊕⊝⊝a,c No 
 
F film   
Fluorescence increases 0.47% more (0.26% to 0.68% 
more) 
2 ⊕⊕⊕⊕ Yes 
 
F varnish   
Fluorescence increases 0.92% more (0.52% to 1.32% 
more) 
3 ⊕⊕⊕⊕e Yes 
 
F miswak   
Fluorescence increases 2.04% more (1.25% to 2.83% 
more) 
1 ⊕⊕⊕⊝a Yes 
  Non-F miswak   
Fluorescence increases 0.32% more (0.97% more to 
0.34% less) 
1 ⊕⊕⊕⊝a,d 
No 
  
Assumed risk per 1000 lesions Corresponding risk per 1000 lesions 
 
 
 Improvement/regression 
of the lesion CPP-ACP 
587 lesions per 1000 regress in the 
control groups. 59 lesions more regress (264 fewer to 699 more) 
2 ⊕⊕⊕⊝d 
No 
  F gel   176 lesions fewer regress (411 fewer to 382 more) 1 ⊕⊕⊕⊝d No 
a-risk of bias from methodological issues; downgrade. 
b-imprecision, which however doesn’t affect the decision for/against the intervention; only the precision of the estimate; don’t downgrade. 
c-heterogeneity; downgrade. 
d-imprecision, which affects both the decision for/against the intervention and the precision of the estimate; downgrade. 
e-large effect magnitude in the absence of other serious issues; upgrade.
  
Supplementary material 14. List of persons contacted in this systematic review for clarifications or 
missing data. 
AA Trial entry Inquiry Contact Status 
1 
[No authors included] {NCT00670618} A Prospective, Randomized Clinical Study 
on the Effects of Casein Phosphopeptide-amorphous Calcium Phosphate (CPP-
ACP) Paste on Plaque, Gingivitis and White Spot Lesions in Orthodontic Patients - 
Part 2. Status: Recruiting. 
Trial status 
S. Dauwe / V. 
Noens 
(undelivered); G. 
De Pauw (10.7.16) 
No response. 
2 
[No authors included] {NCT00670670} A Prospective, Randomized Clinical Study 
on the Effects of Casein Phosphopeptide-amorphous Calcium Phosphate (CPP-
ACP) Paste on Plaque, Gingivitis and White Spot Lesions in Orthodontic Patients - 
Part 1. Status: Recruiting. 
Trial status 
3 
[No authors included] {NCT01344473} A Trial of Tooth Mousse to Remineralise 
Post-orthodontic Treatment White Spot Lesions. Status: Completed. 
Trial status D. Bearn (10.7.16) No response. 
4 
[No authors included] {NCT01500187} Fluoride Varnish for Treatment of White 
Spot Lesions. Status: Completed. 
Trial status 
F. Garcia-Godoy 
(10.7.16) 
Answered (11.7.16) 
and clarified; trial is 
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A. Miresmaeili 
(31.7.16) 
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sent data. 
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S. Ruf (31.7.16) 
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released on time 
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sponsor’s consent. 
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free data or 
raw data 
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(31.7.16) 
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 Supplementary material 15. Additional information for this systematic review 
 
Author contributions 
TE and SNP conceived the idea. DH and SNP wrote the first draft of the protocol. DM, MHZ, 
SNP, and TE revised the protocol. SNP performed the literature searches and extracted search 
hits. DH did screening by title, abstract, fulltext, data extraction, and risk of bias, while MHZ 
checked all procedures afterwards in duplicate, and SNP resolved discrepancies. SNP handled 
communications with trialists and performed the statistical analysis. DM wrote the first draft of 
the manuscript. DM, MHZ, SNP, and TE assisted in the interpretation of the results and revised 
the manuscript draft. TE submitted the manuscript, is the guarantor and responsible for the 
accuracy of the data and for future updates of the review. 
 
 
Post hoc changes to the protocol 
 The outcomes chosen for the GRADE analyses were modified, according to the trials 
that were identified. We reduced the number of included outcomes from 7 that were 
planned in the protocol to 3, as these were the only ones with meta-analysis possible. All 
outcomes that were reported from the studies are listed in the paper. 
 We used the standardized mean difference as effect measure in one instance, as the 
same outcome (enamel fluorescence) was measured with two devices (QLF imaging and 
DIAGNOdent) and the sensitivity analyses indicated that differences existed between the 
two measurements (one measurement method resulted in twice the SDs of the other 
methos—so the SMD was chosen to pool these). 
 Several additional subgroup analyses were planned, but could not be performed. 
  The number needed to treat was planned to be used to clinically translate the results of 
statistically significant meta-analyses of binary outcomes, but no significant binary 
outcomes existed. 
 We considered post hoc to conduct a network meta-analysis to combine direct and 
indirect evidence and rank the available treatments according to their efficacy. Given 
however, the scarce comparisons between some treatments, the risk of bias problematic, 
and the fact that for the meta-analysis with the most studies (outcome of fluorescence) 
variation in the outcome measurement method was observed, we choce not to perform 
this post hoc analysis. 
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Supplementary material 16. Network plot showing the available comparisons for the meta-analysis with the largest 
number of contribution studies (enamel fluorescence) along with number of trials for each comparison and their risk of 
bias. The plot was considered post hoc to explore the feasibility of a network meta-analysis, which was however, not 
conducted. 
